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Aar2p is an essential yeast protein involved in pre-mRNA splicing and 
component of a U5 snRNP precursor form. It has been suggested that the mature U5 
snRNP and U4/U6.U5 tri-snRNP assemble from the Aar2p-U5 core particle that is 
formed in the cytoplasm. After nuclear import, Aar2p would be displaced from its 
interaction with Prp8p in the Aar2p-U5 particle and the mature U5 snRNP would be 
formed by interaction of Brr2p with Prp8p. In one model, Aar2p acts as a transport 
factor either for nuclear import of the Aar2p-U5 particle, or for nucleocytoplasmic 
shuttling of Prp8p. As a non-mutually exclusive alternative, Aar2p can function as a 
chaperone, regulating the Prp8p/Brr2p interaction. 
In this thesis I investigate the role of Aar2p in U5 snRNP biogenesis. I 
demonstrate by fluorescence microscopy that Aar2p is not required for nuclear 
localisation of the U5 snRNP components Snu114p and Prp8p. By a yeast two-hybrid 
(Y2H) assay I establish that Prp8p1649-2413 interacts with Aar2p1-170 but not with 
Aar2p150-355. I also show for the first time that Aar2p is phosphorylated in five 
aminoacids: S253, T274, Y328, S331 and T345. In my Y2H system S253 
phosphorylation disrupts the Aar2p/Prp8p interaction. This suggests a mechanism 
whereby formation of the mature U5 snRNP and activation of Brr2p by Prp8p may be 
regulated through phosphorylation. Surprisingly, when the S253A and S253E 
mutations are inserted into genomic AAR2 there is no change in the amount of Prp8p 
and U5 snRNA immunoprecipitated by Aar2p. 
Finally, using Aar2p1-170 as bait for a Y2H screen, a variety of new Aar2p 
interactors are revealed. The obtained preys include the other half of Aar2p itself, 
proteins involved in DNA damage repair, chromatin-binding, ubiquitin-binding and 
membrane proteins. Overall these results suggest that besides modulating splicing, 
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CHAPTER 1 - Introduction 
 
1.1 Pre-mRNA splicing 
Pre-mRNA (precursor of messenger RNA) is the immediate product of 
transcription by RNA polymerase II, enclosing all the information encoded on DNA. 
Pre-mRNA is composed of introns (non-coding sequences) and exons (the sequences 
retained in the mature mRNA – usually coding sequences). 
Introns are a substantial component of genomes and can be divided into several 
groups according to their mechanism of removal: group I, group II, nuclear precursor 
messenger RNA (pre-mRNA) and tRNA introns (Stoltzfus, 2001). If the gene 
contains one or more introns, in order to serve as a template for translation, the 
pre-mRNA has to be processed - the introns have to be removed and the flanking 
exons have to be joined by a process designated splicing (Berget et al., 1977; Chow 
et al., 1977). Despite showing extremely divergent sequences, three short regions of 
consensus sequence identify pre-mRNA introns and are active agents in the splicing 
reaction: the 5’ splice site, the branchpoint and the 3’ splice site. 
Splicing is a basic process, conserved across eukaryotes and its disruption can 
lead to various serious diseases (Wang & Cooper, 2007). The majority of higher 
eukaryote genes contain more that one intron. This feature permits exons to be joined 
in multiple combinations, by a process denominated alternative splicing (Leff et al., 
1986). Alternative splicing adds an extra level to the eukaryotic proteome 
complexity, allowing different protein isoforms to be expressed from the same 
genomic sequence. All this is due to a change in the splice-site recognition that can 
be mediated by several factors (Keren et al., 2010). 
One of the most widely used model organisms to study pre-mRNA splicing is 
the budding yeast, Saccharomyces cerevisiae. Found in only a small percentage of 
genes in S. cerevisiae (approximately 4%), budding yeast introns are usually 
relatively short and are generally located near the pre-mRNA 5’ end (Beggs, 2001). 





1.2 The splicing reaction 
Intron removal and simultaneous exon ligation are accomplished by two 
sequential transesterification reactions. First the 2’ hydroxyl group of the intron 
branchpoint adenosine causes a nucleophilic attack to the phosphate at the 5’ splice 
site resulting in cleavage of the phosphodiester bond. From this appear: a free 3’ 
hydroxyl in exon 1; and a covalent ligation (2’–5’ phosphodiester bond) between the 
5’ end of the intron and the branchpoint adenosine, resulting in an intron–exon 2 
branched lariat structure. Secondly, the free 3’ hydroxyl of exon 1 brings about a 
nucleophilic attack at the 3’ splice site and cleaves it. A 3’–5’ phosphodiester bond 
joins the exons at the same time the intron is released, with messenger RNA being 




Figure 1.1. The splicing reaction. The intron is removed and the exons are joined 
by two sequential transesterification reactions. 
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1.3 The splice sites 
The 5’ splice site, the branch point and the 3’ splice site are one of the few 
segments of conserved sequences on pre-mRNA introns. They were identified in 
1982 (Mount, 1982) by yeast and mammalian intron sequence comparison. 
In yeast the 5’ splice site consensus sequence is R/GUAUGU (the cleavage site 
is indicated by / and R represents a purine); the branchpoint sequence is UACUAAC 
(the underlined A represents the branchpoint adenosine); and the 3’ splice site is 
YnYAG (Y represents a pyrimidine) and is preceded by a pyrimidine-rich sequence 
(Green, 1986). 
 
1.4 The spliceosome 
In yeast and metazoa, pre-mRNA splicing is catalysed by the spliceosome; a 
large ribonucleoprotein complex formed by the ordered association of five small 
ribonucleoprotein particles (snRNPs) U1, U2, U5, U4/U6 onto each intron (Wahl et 
al., 2009). Non-snRNP proteins also take part in spliceosome assembly (Jurica & 
Moore, 2003). Through spliceosome assembly and the splicing process itself, several 
conformational rearrangements of RNA/RNA, RNA/protein and protein/protein 
interactions occur; the specificity, accuracy and efficiency of which are protein-
regulated (Staley & Guthrie, 1998). 
 
1.4.1 Spliceosome assembly 
Spliceosome assembly is a highly dynamic and complex process that requires 
ATP hydrolysis (Staley & Guthrie, 1998). There are also numerous conformational 
rearrangements before and during pre-mRNA splicing catalysis (Fabrizio et al., 
2009; Warkocki et al., 2009). 
Commitment Complex (CC) formation is the first step in spliceosome 
assembly (Figure 1.2). It takes place co-transcriptionally and consists of U1 
association with the 5’ splice site and Bbp1 (Branchpoint Binding Protein) 
interaction with the branchpoint region (Kotovic et al., 2003; Gornemann et al., 
2005; Lacadie & Rosbash, 2005). Watson-Crick base-pairing between the U2 snRNP 
and the branchpoint sequence forms the complex A. As there is incomplete 
complementation between the two sequences, the branchpoint adenosine is projected 
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from the U2 snRNA/pre-mRNA duplex. This feature later boosts the characteristic 
first splicing step nucleophilic attack. Next, the Nineteen complex proteins (NTC) 
and the U4/U6.U5 triple snRNP associate with complex A giving rise to complex B. 
After unwinding of the U4/U6 base pairing, U2/U6 interaction and U1 and U4 
dissociation from the spliceosome, the catalytically active B* complex is formed. 
This complex catalyses the first splicing step, after which the spliceosome changes 
conformation to complex C, proceeding to the second splicing step (Konarska 2008; 







Figure 1.2. Spliceosome assembly in pre-mRNA splicing – figure adapted from Hogg et al. 
(2010). The U1, U2 and U4/U6.U5 tri-snRNP associate in a sequential manner onto the pre-mRNA to 
assemble the spliceosome. A series of rearrangements occur and the spliceosome adopts different 
conformations throughout the splicing reaction (Complexes A, B, B* and C). The Nineteen complex 
of proteins (NTC) is recruited to the spliceosome along with the snRNPs and is essential for the 
conformational rearrangements in both splicing steps 1 and 2. It is believed that the snRNPs are 
recycled after each round of splicing to carry out subsequent splicing reactions. The mauve arrows 
represent the spliceosome transition to the next conformational state; the black arrows indicate the 
addition or removal of components from the spliceosome. 
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It is believed that the spliceosome needs to be re-assembled for each new round 
of splicing and its components are recycled from previous splicing reactions 
(Makarov et al., 2002). 
 
1.5 snRNPs 
The snRNPs (small nuclear Ribonucleoprotein Particles) were described as 
being involved in splicing in 1980 (Lerner et al., 1980). They are trans-acting factors 
composed of RNA and protein, receiving their name according to the spliceosomal 
small nuclear RNA (snRNA) they contain (Lerner & Steitz, 1979). snRNAs are vital 
in splice sites alignment and are thought to contribute to the spliceosome catalytic 
core together with some of their associated proteins (Wachtel & Manley, 2009). Two 
groups of proteins associate with snRNAs in the snRNPs: snRNA-specific proteins, 
and Sm proteins (B, D1, D2, D3, E, F and G). 
 
1.5.1 snRNPs biogenesis 
Most of the actual knowledge on snRNP biogenesis (Figure 1.3) comes from 
studies in Metazoan species (reviewed in Will & Luhrmann, 2001; Kiss, 2004; Patel 
& Bellini, 2008). 
The U1, U2, U4 and U5 snRNAs are transcribed by RNA polymerase II in the 
nucleus. Export factors CRM1 and PHAX together with nuclear cap-binding proteins 
assist in the snRNAs nuclear export (Hamm & Mattaj, 1990; Izaurralde et al., 1995, 
1997; Fornerod et al., 1997; Ohno et al., 2000). Once in the cytoplasm snRNP 
assembly is initiated. The hetero-heptameric Sm protein complex, required for 
snRNA metabolic stability, 5’ cap hypermethylation, 3’ end processing and snRNA 
nuclear import, is assembled on the snRNAs. Importin β, Snurportin1 and the SMN 
complex are responsible for snRNP nuclear import via interaction with the Sm 
complex and with the snRNA m3G cap (Fischer et al., 1997; Palacios et al., 1997; 
Huber et al., 1998). The snRNP maturation is only completed with the association of 
snRNP-specific proteins. 
Most of what is known for snRNP biogenesis comes from studies in Xenopus 
oocyte and mammalian cells, regarding U1 and U2 snRNPs (Will & Luhrmann, 
2001; Kiss, 2004; Patel & Bellini, 2008). Specific U1 and U2 proteins associate at 
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nuclear Cajal bodies with the core-snRNP. The nuclear import of these proteins is 
autonomous from the snRNAs import (Jantsch & Gall, 1992; Romac et al., 1994; 
Hetzer & Mattaj 2000; Nesic et al., 2004). In Xenopus oocytes, U5 snRNP precursor 
nuclear import is independent from m3G cap (Fischer et al., 1991) and is not known 
when it associates with U5-specific proteins. 
 
 
Figure 1.3. Schematic overview of snRNPs biogenesis in high eukaryotes. Figure from Kiss 
(2004). 
 
The U6 does not bind to Sm proteins but is associated with seven Lsm (Sm-
like) proteins. U6 snRNA is an RNA polymerase III product and it is kept in the 
nucleus after 5’ γ-monomethyl phosphate capping (Will & Lührmann, 2001; Kiss, 
2004; Beggs, 2005). 
Saccharomyces cerevisiae snRNP biogenesis has not been extensively studied. 
For instance, there are no described orthologs for PHAX export factor or Snurportin1 
import factor in budding yeast. Nevertheless, data from Boon et al. (2007) show that 
U5 snRNP has a cytoplasmic stage and its nuclear import is dependent on Prp8p, a 
 8 
specific U5-snRNP protein and component of the U4/U6.U5 tri-snRNP. The same 
authors suggest that this Prp8p-dependent U5 nuclear import might be conserved in 
other species, explaining why in Xenopus oocytes U5 import is m3G cap 
independent. 
 
1.6 U5 snRNP 
The U5 snRNP is one of the spliceosome main components. It contacts the 
exon sequence adjacent to the 5’ splice site prior to the first step of splicing and then 
maintains its hold, later aligning the ends of the two exons for ligation in the second 
step (Grabowski & Sharp, 1986; Frilander & Steitz, 2001; Wahl et al., 2009). 
U5 snRNA loop 1, an invariant 9-nucleotide sequence, enabled U5 snRNA 
encoding gene identification - SNR7 in S. cerevisiae (Patterson & Guthrie, 1987). 
The U5 loop 1 together with the U5 snRNP protein Prp8p are vital for alignment of 
the exon ends for the second splicing step, Figure 1.4 (Umen & Guthrie, 1995; 




Figure 1.4. U5 snRNA loop 1 and Prp8p align the exons for the second splicing step. Both Prp8p 
protein and U5 snRNA loop 1 are essential to align the exons for the second splicing step after which 




There are two U5 snRNA forms differing in 3’ end length U5S (short) and 
U5L (long). RNase III catalyzes U5-3’ end processing and is responsible for this 
phenomenon (Chanfreau et al., 1997). Both U5S and U5L are found in spliceosomes. 
Two U5 snRNP forms were found in S. cerevisiae. The mature and functional 
form contains the U5 snRNA, Sm proteins, Prp8p, Snu114p, Brr2p, Prp28p, Snu40p 
and Dib1p (Stevens et al., 2001). A form with unknown function that contains U5 
snRNA, Sm proteins, Prp8p, Snu114p and Aar2p has been proposed as a precursor or 
intermediate in U5 snRNP biogenesis and/or recycling (Gottschalk et al., 2001). 
A model for U5 snRNP maturation was proposed (Figure 1.5) in which the 
Aar2p-U5 snRNP complex is an intermediate particle in U5 snRNP biogenesis and is 
formed in the cytoplasm (Boon et al., 2007). Once in the nucleus, the Prp8p/Aar2p 
interaction is disrupted allowing Brr2p to interact with Prp8p to form the mature and 
active U5 snRNP. In this model, Prp8p/Aar2p and Prp8p/Brr2p interactions are 




Figure 1.5. The U5 snRNP maturation model – figure adapted from Boon et al. (2007). Boon et 
al. (2007) proposed a model for U5 snRNP maturation in which the Aar2p/Prp8p and Brr2p/Prp8p 
interactions are mutually exclusive. The Aar2p/Prp8p/Snu114p/U5 precursor form is assembled in the 
cytoplasm and subjected to nuclear import dependent on Kap95p. Once in the nucleus, the mature U5 
snRNP would be formed, replacing Aar2p with Brr2p in the Prp8p/Snu114p/U5 complex. As a result, 
it is expected that an equilibrium will be established between the Aar2p/Prp8p/Snu114p/U5 and 
Brr2p/Prp8p/Snu114p/U5 complexes in the nucleus. 
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1.6.1 Major U5 snRNP proteins 
One of the most important steps in the spliceosome activation, the U4/U6 
dimer unwinding, is dependent on U5 snRNP proteins: Prp8p (Kuhn et al., 1999), 
Brr2p (Raghunathan & Guthrie, 1998; Kim & Rossi, 1999; van Nues & Beggs, 2001) 
and Snu114p (Bartels et al., 2002, 2003; Brenner & Guthrie, 2005). These three 
proteins form a stable complex at the core of U5 snRNP and remain associated 
throughout the entire splicing reaction (Achsel et al., 1998; Fabrizio et al., 2009). 
 
Prp8p 
RNA8 (PRP8) was first identified in 1967 from a genetic screen to isolate 
temperature-sensitive mutations in S. cerevisiae (reviewed in Grainger and Beggs, 
2005). Due to its essential contribution to pre-mRNA processing, RNA8 was 
renamed PRP8 (Vijayraghavan et al., 1989). Several studies contributed to the 
comprehension of PRP8 function, mainly immunodepletion and 
immunoprecipitation experiments done with antibodies raised against different Prp8p 
domains (Lossky et al., 1987; Jackson et al., 1988; Anderson et al., 1989; Whittaker 
et al., 1990; Brown & Beggs, 1992; Hinz et al., 1996; Luo et al., 1999). These 
experiments demonstrated that Prp8p joins the spliceosome very early and remains 
through both the first and second splicing steps. It is also found together with the 
excised intron in the post-splicing complex. 
Prp8p requirement for splicing is ubiquitous, although in humans its expression 
level is higher in cardiac and skeletal muscle (Luo et al., 1999). It is the largest (280-
kDa in budding yeast) and most highly conserved splicing factor (Grainger & Beggs, 
2005) and regulates several conformational rearrangements in the spliceosome. 
Numerous Prp8p interactions with other proteins were identified (van Nues & Beggs, 
2001; Grainger & Beggs, 2005; Boon et al, 2006). Amongst these, are interactions 
with Snu114p and Brr2p. 
It was thought that alignment of the exon ends during the splicing reaction was 
the responsibility of U5 snRNA loop 1 (O’Keefe et al., 1996). Nevertheless it was 
shown that splicing still occurs in the absence of U5 loop 1 (Segault et al., 1999); 
moreover, it is necessary just for the second splicing step in yeast extracts (O’Keefe 
et al., 1996; O’Keefe & Newman, 1998). Besides, both pre-mRNA 5’ and 3’ splice 
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sites contact Prp8p (Whittaker & Beggs, 1991; Teigelkamp et al., 1995); and in U5 
loop 1 absence, Prp8p cross-links to 3’ splice sites (Dix et al., 1998). This indicates 
that Prp8p together with U5 loop 1 are crucial anchoring factors in 
spliceosome/exons interactions and may contribute to exon end alignment for the 
second splicing step (Dix et al., 1998; O’Keefe & Newman, 1998). Prp8p gets 
destabilized with mutations on U5 loop 1 affecting pre-mRNA splicing. This can be 
one of the reasons why U5 loop 1 sequence is so conserved (Kershaw et al., 2009). 
Prp8p is a large protein composed of several domains (Grainger & Beggs, 
2005; see Figure 1.6). Basically it contains a nuclear localization signal (NLS) at the 
N-terminus, an RNA recognition motif (RRM) at the centre, an RNaseH and a 
Jab1/MPN domain at the C-terminus (Maytal-Kivity et al., 2002; Grainger & Beggs, 
2005; Pena et al., 2007; Pena et al., 2008). From the RNaseH domain a β-hairpin 
finger similar to the ones found in ribosomal proteins is projected, which helps in 
stabilizing the RNA structure in the ribosome (Yang et al, 2008). 
Prp8p NLS is located between amino acids 96-117 and Kap95p is responsible 
for its nuclear uptake (Boon, 2005; Boon et al., 2007). When this NLS is deleted, 
Prp8p, which is normally concentrated in the nucleus, is delocalized to the cytoplasm 
together with U5 snRNA and Snu114p. An increased association of Prp8∆NLSp with 
Aar2p was also observed, and lower levels of Prp8∆NLSp associated with Brr2p and 
U4 and U6 snRNAs. This suggests a deficiency in mature U5 snRNP and tri-snRNPs 
formation, probably due to retention of precursor U5 snRNP in the cytoplasm that 
might need Prp8p for translocation into the nucleus (Boon et al., 2007). 
Crystal structures of the human and yeast Prp8p RNase H domain showed that 
it is conserved between species. This domain interacts with the key sequences on the 
pre-mRNA: the 5’ ss, the branchpoint and the 3’ ss. It also interacts with the U4/U6 
di-snRNP and with Brr2p (Pena et al., 2008). The same study suggests that this 
domain contributes to the assembly and stabilization of the catalytic core of the 
spliceosome and can also contribute to splicing catalysis (Pena et al., 2008). 
Mutational analysis showed Prp8p β-finger to be involved in the transition 
from the first to the second splicing step and also in the U4/U6 unwinding (Kuhn et 




Figure 1.6. Schematic representation of Prp8p domains and their main interactors (see 
main text for detailed description). NLS - nuclear localization signal; RRM - RNA recognition 
motif; 5’ ss - 5’ splice site; bp - branch point; 3’ ss - 3’ splice site; Ub - ubiquitin. 
 
 
Prp8p C-terminal Jab1/MPN domain was shown to bind ubiquitin (Bellare et 
al., 2006), Snu114p and Brr2p (Pena et al., 2007). The crystal structure confirmed 
Jab1/MPN domain organization to be typical for deubiquitinating enzymes (Pena et 
al., 2007). Furthermore, Prp8p-ubiquitin conjugates were isolated within the 
U4/U6.U5 tri-snRNP, insinuating a role for ubiquitination in pre-mRNA splicing 
regulation (Bellare et al., 2008). Pena and colleagues suggest that the Jab1/MPN is a 
pseudoenzyme that during evolution was converted into a protein-protein interaction 
domain (Pena et al., 2007). 
 
Snu114p 
Snu114p is homologous to the ribosomal translocase elongation factor G (EF-
G in prokaryotes/EF2 in eukaryotes) and so far is the only GTPase identified in the 
spliceosome. This suggests that Snu114p might be responsible for spliceosomal 
rearrangements through GTP hydrolysis (Fabrizio et al., 1997). Snu114p comprises 
eight domains, three of which (III-V) are expected to reorganize as a result of GTP 
hydrolysis (Brenner & Guthrie, 2005). Snu114p together with U5 loop 1 is required 
for Prp8p stabilization within the spliceosome (Brenner & Guthrie, 2006; Kershaw et 
al., 2009). 
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Several studies point to a requirement for Snu114p in the assembly of U5 with 
U4/U6 and afterwards for U4/U6 unwinding and U1 release (Bartels et al., 2002, 
2003; Brenner & Guthrie, 2005).  
Work from the Staley lab (Small et al., 2006) suggests that Snu114p is 
involved in both spliceosome activation and disassembly. The authors showed that 
GDP represses post-splicing U2/U6.U5.intron complex disassembly; and that this 
can be reverted by GTP and analogs without hydrolysis in the presence of Brr2p 
(Small et al., 2006). They suggest an innovative mechanism for Snu114p function. 
Going against the general consensus, Small et al. (2006) suggest that Snu114p works 
as a G protein and not as a classic GTPase. They propose that Snu114p, by GTP 
binding, regulates Brr2p unwinding activity towards U4/U6 (and probably U2/U6 
too). Their suggestion is that Snu114p is a signal-dependent switch that controls 
Brr2p along several steps of the splicing reaction, explicitly those of spliceosome 
activation and disassembly. Brr2p would then be responsible for U4/U6 and U2/U6 
unwindings via ATP hydrolysis, as a conventional helicase. This Snu114p control 
over Brr2p can be either direct or indirect (since no direct interaction between 
Snu114p and Brr2p was shown until now), with two putative candidates for the third 
component being U5 snRNA and Prp8p. 
More recently it was proposed that the Snu114p G-domain (GTP binding and 
hydrolysis) detects the U4/U6 and U2/U6 snRNAs base pairing state. Subsequently, 
by its C-terminal domain Snu114p would control Brr2p, which in turn triggers 
RNA/RNA rearrangements in the spliceosome (Frazer et al., 2009). 
 
Brr2p 
Brr2p was first identified as being involved in pre-mRNA splicing in a screen 
for splicing defective cold-sensitive mutants (Noble & Guthrie, 1996). It is a 
DExH-box RNA helicase, composed of an N-terminal domain and two helicase 
modules (one N-terminal and the other C-terminal). Each helicase module is 
composed of a helicase domain followed by a Sec63 domain (Hahn & Beggs, 2010). 
Brr2p N-terminal helicase module is required for U4/U6 unwinding due to its 
ATPase activity (Raghunathan & Gutrie, 1998; Kim & Rossi, 1999). The C-terminal 
helicase module is believed to be responsible for interactions with other proteins and 
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also for controlling the activity of the first helicase domain (reviewed in Hahn & 
Beggs, 2010). 
As mentioned above, Brr2p activity is vital for U4/U6 unwinding and is 
controlled by Snu114p (Frazer et al., 2009). Snu114p-GTP activates Brr2p and 
Snu114p-GDP represses it. By its GTP and phosphorylation states, Snu114p is 
thought to regulate Brr2p activity in spliceosome disassembly in unwinding of 
U2/U6 (Small et al., 2006; Frazer et al., 2008).  
Prp8p also regulates Brr2p helicase activity (Kuhn et al., 1999). It was shown 
that the C-terminal fragment of Prp8p (Prp8p-CTF, Prp8p1806-2413 that contains part 
of the RNaseH and Jab1/MPN domains) represses Brr2p ATPase activity but 
stimulates its helicase activity (Maeder et al., 2009). 
It was observed that disruption of ubiquitin recognition blocks splicing by 
acceleration of U4/U6 unwinding and consequent imbalance in the U4/U6.U5 tri-
snRNP level. The evidence that Prp8p-ubiquitin is co-purified with the tri-snRNP 
further suggests that ubiquitinated Prp8p mediates Brr2p U4/U6 unwinding activity 
(Bellare et al., 2008). 
 
1.7 Retinitis Pigmentosa 
About 1 in 4000 people worldwide suffer from serious visual impairment due 
to Retinitis Pigmentosa (RP) (Wang & Cooper, 2007). The disease is named after the 
accumulation of intra-retinal pigment deposits during the later stages of the disease. 
RP encloses a group of progressively incapacitating, hereditary disorders that cause 
terrible retinal damage, affecting the retina in a centripetal way. The rods (retinal 
photoreceptors responsible for dim light vision) are the first and main RP targets; the 
patients acquire tunnel vision and night-vision is also disturbed. As a consequence, 
the cones (daylight vision photoreceptors) start to die and ultimately central vision is 
lost. In parallel, the retinal vasculature gets weakened and the characteristic intra-
retinal deposits of rhodopsin accumulate (Kennan et al., 2005). 
Approximately 31 RP-causing genes were identified so far and 13 are related 
to autosomal dominant forms of RP (adRP). Amongst these, five are splicing factors: 
PRPF3, PRPF8, PRPF31, SNRNP200 and PAP-1 (reviewed in Kennan et al., 2005; 
Mordes et al., 2006; and Hahn & Beggs, 2010). With the exception of PAP-1, all 
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have orthologs in S. cerevisiae and are tri-snRNP components. This suggests a link 
between adRP and spliceosome assembly, more specifically tri-snRNP formation. 
It is interesting how mutations in ubiquitously expressed splicing factors can 
lead to a retina-specific disease with a late onset. A possible explanation is that the 
retina is a highly metabolically active tissue with an elevated turnover. In the case of 
splicing factors with RP mutations the splicing levels of an important retinal protein 
such as rhodopsin are compromised, resulting in a reduced number or defective 
transcripts that are not enough for the retinal metabolic demands. Additionally 
defective and non-functional protein can aggregate inducing wt protein aggregation. 
This is a cumulative effect with time and the visual abilities of the patient will get 
worse progressively (Kennan et al., 2005; Mordes et al., 2006; Kosmaoglou et al., 
2008). 
Regarding PRPF8, adRP-causing mutations were identified in a 14 codon-
stretch in the last exon. The altered aminoacid residues are highly conserved from 
humans to S. cerevisiae (McKie et al., 2001). Several studies have shown a link 
between RP mutations in hPrp8p (protein encoded by PRPF8 in humans) and Prp8p 
(protein encoded in S. cerevisiae by the budding yeast ortholog of PRPF8), 
Prp8p/Snu114p/Brr2p complex formation and U5 snRNP maturation (Boon et al., 
2007; Pena et al., 2007; Maeder et al., 2009; reviewed in Newman & Nagai, 2010). 
It was observed that RP mutations in the hPrp8p C-terminal deteriorate interactions 
between this region, hSnu114p and hBrr2p (Pena et al., 2007). 
After showing that S. cerevisiae Prp8p-CTF interacts with Brr2p, stimulating 
its ATP-dependent unwinding activity towards a U4/U6 duplex, Maeder and 
colleagues observed that Brr2p activity was strongly affected if the same Prp8p 
fragment contained an RP mutation. As a result, Prp8p RP mutations will have an 
effect on spliceosome activation (Maeder et al., 2009). 
Furthermore, RP mutations lead also to a defect in U5 snRNP maturation in 
yeast. Prp8p RP mutations caused the Aar2p-U5 snRNP precursor form to 
accumulate at the same time as a decrease in Brr2p-U5 snRNP mature form was 
detected. In consequence a reduction in the U4/U6.U5 tri-snRNP level and splicing 
defects were also observed (Boon et al., 2007). 
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Recent studies showed a connection between mutations in hBrr2p and RP 
(Zhao et al., 2009; Li et al., 2009). The same mutations in budding yeast lead to a 
deficient U4/U6 unwinding but do not affect the tri-snRNP levels, implying therefore 
U5 snRNP maturation defects (Zhao et al., 2009). 
 
1.8 Aar2p 
Aar2p is an essential protein, and component of the U5 snRNP (required for 
both in vivo and in vitro splicing) but not of the U4/U6.U5 tri-snRNP (Gottschalk et 
al., 2001). It has been suggested that Aar2p has a role in snRNP recycling since its 
depletion has a negative effect on later rounds of splicing. 
It is suggested that the yeast mature U5 snRNP and U4/U6.U5 tri-snRNP 
assemble from a putative Aar2p-U5 core particle (Gottschalk et al., 2001; Boon et 
al., 2007).  
Nakazawa et al. (1991) first described Aar2p as being required for MATa1 pre-
mRNA splicing but not for ACT1 splicing. In the same paper, both aar2-1 and aar2-
2 mutants led to severe growth defects and AAR2 disruption seems to be lethal. By 
primer extension it was verified that there is a defect in splicing the two MATa1 pre-
mRNA short introns in both mutants and disrupted AAR2. Introducing an intronless 
MATa1 restores the alpha mating type but not the growth phenotype. This suggests 
that AAR2 is required also for splicing of gene(s) essential for cell growth. Aar2p 
sequence comparison revealed a leucine zipper structure between aminoacids 
261-282 that can be implicated in homo- or heterodimerization. There is also an 
acidic region between aminoacids 332-341. The authors suggested that the level of 
AAR2 transcript is very low in the absence of appropriate mating pheromone 
induction. This is suggested because there is one copy of a pheromone-responsive 
element (5'-TGAAACA-3') at positions -398 to -392, and three copies of inverted 
sequences of this element with incomplete matches at positions -98 to -92, -294 to 
-288, and -416 to -410 of AAR2. Also, these authors could not detect AAR2 transcript 
in logarithmic growth phase (Nakazawa et al., 1991 - data not shown). 
Gottschalk et al. (2001) found that Aar2p is specifically associated with U5 but 
not with the tri-snRNP (IPs from total cell extracts with αAar2p and Northern blot 
analysis of coprecipitated RNAs; plus, a complementary experiment followed by 
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glycerol gradient assaying each fraction by Northern and Western blots). There is a 
fraction of Aar2p at the top of the gradient that is thought to be unbound Aar2 
protein. Aar2p-U5 was invariably coisolated with U1, regardless of the purification 
protocol used by these authors (PGAL1-AAR2-His strain, total cell extract and 2-step 
affinity purification). They verified that Aar2p is required for pre-mRNA splicing in 
vivo but not in vitro of U3 or ACT-1 pre-mRNAs. Removal of Aar2p resulted in a 
reduction of 25S tri-snRNP levels, which are still sufficient to support in vitro 
splicing. Aar2p depletion interferes with later rounds of splicing and recombinant 
Aar2p partially complemented the Δaar2 splicing defect. These last results led to the 
suggestion that Aar2p has a role in snRNP recycling (Gottschalk et al., 2001). 
The splicing reaction is thought to be under quality control by a putative 
discard pathway. If aberrant complexes are formed throughout the splicing reaction, 
the discard pathway is activated to remove them (Konarska and Query, 2006). The 
DEAH box ATPase Prp43p is one of the main responsibles for this process (Pandit et 
al., 2006; Mayas et al., 2010). In a suppressor screen to identify components the 
discard pathway (Pandit et al., 2006) an AAR2 mutant allele D281N=aar2G841A that 
acts as a prp38-1 suppressor was identified. The prp38-1 mutants are ts 
(temperature-sensitive) due to splicing impairment at an early stage of the reaction – 
slow U1 and U4 release. So, for D281N=aar2G841A to suppress this effect, Aar2p 
has to be either a factor that enhances splicing efficiency or that is involved in 
defective spliceosome turnover. This later alternative is more plausible since it was 
shown that Aar2p depletion has a negative effect in later rounds of splicing 
(Gottschalk et al., 2001). 
Regarding Aar2p physical interaction with components of the intermediate U5 
snRNP, it was observed that disruption at Prp8p2173 interferes with Prp8p association 
with Aar2p. In the same study, the amount of Aar2p associated with Prp8p771-2413 was 
increased compared to the full-length Prp8p (Boon et al., 2006).  
Kutach (Guthrie lab, unpublished data – personal communication) purified 
Prp8p-CTF from yeast and identified one co-purifying protein - Aar2p - and no 
Brr2p. An in vitro mixture of Aar2p, Brr2p and Prp8p-CTF resulted in the formation 
of a Prp8p/Aar2p/Brr2p complex. Prior binding of Brr2p to Prp8p does not inhibit 
interaction of Aar2p with Prp8p-CTF. Pre-binding an excess of Aar2p to CTF 
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inhibits binding of Brr2p. CTF binds to Aar2p with a higher affinity than CTF-N in a 
direct competition, even though he did not detect a direct interaction between the 
first two. He suggests that Aar2p binds to CTF-N and clamps down the CTF-C 
impairing Brr2p binding to this region. 
With reference to other aspects that might help in understanding Aar2p 
mechanism, Albuquerque et al. (2008) identified Aar2p as being phosphorylated at 
S331. Aar2p phosphorylation state may well control Aar2p activity and also regulate 
its interaction with other proteins. Ptacek et al. (2005) identified Aar2p, Lsm12p and 
Prp40p as in vitro substrates for Prr2p kinase using proteome chip technology. 
Another kinase - Gcn2p - was identified as a physical interactor of Aar2p, Brr2p, 
Prp4p, Prp6p, Prp8p, Prp31p, Sun66p and Snu114p in a genome-wide screen (Gavin 
et al., 2006). 
Aar2p was found as a prey in two independent yeast two-hybrid assays. The 
first one used Psf2p as bait (Hazbun et al., 2003). Psf2p is a GINS complex 
component responsible for DNA replication machinery assembly to replication 
origins (Takayama et al., 2003; Kanemaki et al., 2003). In the second screen (Yeast 
Resource Center, Fields S. – unpublished data) the bait was Rgd2p, which is a 
Cdc42p and Rho5p GTPase activating protein (RhoGAP) (Roumanie, et al., 2001). 
Despite the data gathered around Aar2p its exact role in pre-mRNA splicing is 
still unclear. 
 
1.9 Aim of this work 
As described above, U5 snRNP biogenesis is a relevant step for spliceosome 
assembly and its disruption leads to splicing defects in general and can lead to 
diseases like retinitis pigmentosa in humans in particular. Hence there is an increased 
interest in understanding how this essential process is regulated. 
To gain a better understanding of U5 snRNP biogenesis, in this work I 
investigate the role of an understudied protein - Aar2p - in this process. The obtained 
results are put into context with the proposed U5 snRNP maturation model (Boon et 
al., 2007). According to this model, the balance between the mutually exclusive 
Aar2p/Prp8p and Brr2p/Prp8p interactions is thought to be vital for correct U5 
snRNP maturation (Boon et al., 2007). 
 19 
I use S. cerevisiae as a model system as the overall splicing mechanism is 
conserved relative to higher eukaryotes. Also, its undemanding lab manipulation 
makes it a perfect model to study Aar2p in vivo using a combination of molecular 
biology techniques, biochemical assays and live imaging. 
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CHAPTER 2 - Materials and Methods 
 
2.1 Chemicals and reagents 
General chemicals were acquired from Sigma, Amersham, Thermo-Scientific, 
Roche, Invitrogen, Pierce, Biorad. 
Reagents for yeast media were purchased from Formedium. 
 All restriction enzymes were bought from New England Biolabs; DNA 
polymerases from Promega and Roche. 
 
2.1.1 Oligonucleotides 
Oligonucleotides were either purchased from Sigma or Invitrogen. 
 
Name Sequence 5’-3’ Notes 
U5-7wtsmnr AAGTTCCAAAAAATATGGCAAGC Boon 2005 
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Plasmid Description Source 
pGEX4T1-Aar2 Bacterial expression vector with 
GST-Aar2p 












Fromont-Racine et al., 
1997 
pACTII-stop-E1 pACTII-stop with Prp8p1649-2413 van Nues & Beggs, 2001 
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pACTII-stop with Prp8p2010-2413-prp8-52 
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NAT cassette for genomic insertion 
 
























































   




















2.1.3 E. coli strains 
Strain Genotype Source 
DH5α lacZM15 (lacZYA-argF) recA1 endA1 hsdR17 (rk-, mk+) phoA supE44 










2.1.4 Yeast strains 
Strain Genotype Source 
AGY8 trp1-Δ; his3Δ; ura3-52; lys2-801; ade2-101; 
aar2Δ::URA3+pRS314-GAL1::AAR2-10xHis, ARS, 
CEN, TRP1 




MATa; ade2; trp1-901; leu2-3; -112; lys2-801am; 
his3Δ200; LYS2::(lexAop)4-HIS3; URA3::(lexAop)8-

























W303α with SPC105:13Myc-kanMX6 
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2.1.5 Bacterial and yeast growth media 
All the media solutions were autoclaved and kept at room temperature. For 
solid media 2% (w/v) bacto agar was added before autoclaving. For the Y2H assays 
3-Amino-1,2,4-triazole (3AT) was added to drop-out media after autoclaving. 
 
Medium Composition 
Luria-Broth (LB) 1 % (w/v) bacto-tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl, pH 7.2 
  
YPDA 1% (w/v) yeast extract, 2% bacto-peptone, 2% (w/v) glucose, 0.003% (w/v) 
adenine sulphate 
  
YPGR 1% (w/v) yeast extract, 2% bacto-peptone, 2% (w/v) galactose, 2% (w/v) 
raffinose, 0.003% (w/v) adenine sulphate 
  
YMM drop-out 0.67% yeast nitrogen base without aminoacids, 2% (w/v) glucose, drop-out  
powders were added according to manufacturer instructions and pH adjusted 
with 0.1g NaOH per 500 mL 
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2.1.6 Commonly used buffers 
Buffer Composition/Litre 




1 M MOPS (3-N-morpholine) propane sulfonic acid, 1M Tris, 2% (w/v) SDS, 








54g Tris base, 27.5g boric acid, 20 mL 0.5 M EDTA 
 
10x Western 
transfer buffer  
 





















1 kb plus DNA Ladder – Invitrogen 100 bp - 12 kb 
 






Antibody Description Source 




rabbit IgG, primary and immunoprecipitation 
 



































LexA sc7544 mouse monoclonal IgG, 
immunoprecipitation 
 













   
αHA (Y-11) HA sc-805 rabbit polyclonal IgG, primary Santa Cruz 
Biotechnology 
















αPhospho-threonine mouse mAb Cell Signaling 
Technologies 
 




αrabbit IgG Horseradish Peroxidase linked F(ab’)2 













αmouse IgG Horseradish Peroxidase conjugated 






2.2 Microbiology protocols 
2.2.1 Propagation, storage and bacteria transformation 
Growth, storage, preparation and transformation of competent E. coli were 
performed as described in Sambrook & Russel, 2001. 
 
2.2.2 Propagation, storage and yeast transformation 
Growth and S. cerevisiae storage were performed as described in Methods in 
Yeast Genetics, 2000. The lithium acetate method was used for yeast transformation 
(Gietz et al., 1991). 
 
2.3 Molecular Biology protocols 
2.3.1 DNA sequencing 
PCR reactions for DNA sequencing were prepared with appropriate oligos for 
each situation and with BigDye Terminator Cycle Sequencing Ready Reaction 
from Applied Biosystems. Samples were sequenced by the SBS Sequencing Service, 
Ashworth Laboratories, University of Edinburgh. 
 
2.3.2 Site-directed mutagenesis 
Site-directed mutagenesis (SDM) was used to generate the Aar2p 
phosphomutations. Each oligonucleotide pair containing the desired mutation was 
designed to be complementary of the pBTM116-1-Aar2p plasmid. PFU DNA 
polymerase from PROMEGA was used in the PCR reaction. For the 50 µL PCR 
reaction were used: 36 µL H2O, 5 µL PFU 10x Buffer, 2.5 µL dNTP mix (10 mM 
each), 2.5 µL of each of the two complementary oligonucleotides (10 mM stock), 0.5 
µL plasmid DNA template and 1 µL PFU DNA polymerase. PCR conditions use 
were as follow: 
1. Denaturing 1   92˚C, 2 min 
2. Denaturing 2   92˚C, 30 s 
3. Annealing       60˚C, 40 s 
4. Extension        68˚C, 8 min 
5. Repeat steps 2-4, 25 times 
6. Final extension 68˚C, 10 min 
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The PCR products were treated with DpnI for 3 h to 10 h. After the digestion 
the reactions were cleaned with Wizard Gel and PCR cleaning kit from PROMEGA. 
The mutated plasmids were used to transform competent DH5α E. coli. The obtained 
clones were isolated and the mutations confirmed by DNA sequencing. 
 
2.3.3 Nucleic acids techniques 
Sambrook & Russel, 2001 was used a general guide for nucleic acids 
techniques: ethanol precipitation, deproteinisation, endonuclease DNA digestion, 
DNA ligation, DNA agarose gel electrophoresis and E. coli plasmid DNA isolation. 
 
2.3.4 Genomic integration of phospho-mutations 
The plasmids obtained from step 2.3.2 were used as templates to clone 
fragment of phospho-mutated aar2 into the pGID3 plasmid. This plasmid includes a 
prMFα2NatR cassette for NAT selection and is a tool to insert the phospho-mutations 
into genomic AAR2 by homologous recombination. Due to the lack of compatible 
restriction sites between pBTM116-1 and pGID3 plasmids, In-Fusion PCR cloning 
system from Clontech was used to transfer mutant aar2 sequences (containing each 
phospho-mutation) from the pBTM116-1-Aar2 templates to the pGID3 plasmid. The 
aar2 fragments were amplified from pBTM116-1 by PCR, using oligos designed to 
promote the fusion between the ends of each PCR fragment to the linearized ends of 
pGID3. 
After the phospho-mutant sequences were inserted immediately 5’ to the 
prMFα2NatR cassette in pGID3, a second PCR was preformed to amplify aar2 with 
the cassette. These PCR products were integrated into yeast cells by homologous 
recombination, replacing part of the AAR2 genomic sequence with each mutant aar2 
fragment plus prMFα2NatR cassette. The genomic integration was confirmed by 
Yeast colony PCR followed by sequencing. This was done with appropriate sets of 
oligos to verify cassette integraton into the correct locus and confirm the presence of 





2.4 Biochemical protocols 
2.4.1 Crude yeast extract 
3 OD units (OD600) of a yeast strain grown until stationary phase were spun 
down and the pellet was resuspended in 500 µL of 0.2 M NaOH and incubated on ice 
for 10 min. Then, 50 µL of 50% TCA were added and the sample left on ice for 
further 10-30 min. The mixture was spun down at 14000 rpm for 5 min. The pellet 
was resuspended in 35 µL of dissociation buffer (100 mM Tris pH 6.8; 4 mM EDTA 
pH 8.0; 4% SDS; 20% glycerol; 2% β-mercaptoethanol and some bromophenol 
blue). The sample pH was adjusted by the addition of 15 µL of 1M Tris buffer (non-
adjusted pH). Sample was boiled for 10 min at 95˚C. At this point samples were 
either loaded in a gel or stored at -20˚C. 
 
2.4.2 Yeast genomic DNA preparation 
3 OD units (OD600) of a yeast strain grown until stationary phase were spun 
down. Cells were resuspended in 300 µL of lysis solution (4.22 µL H2O; 100 µL 
Triton X-100; 500 µL 10% SDS; 125 µL 4 M NaCl; 50 µL 1M Tris-HCl pH 8.0; 10 
µL 0.5M EDTA). Approximately 300 mg of zirconia beads were added together with 
300 µL of phenol:chloroform:isoamyl alcohol solution and the mixture was vortexed 
for 6 min at 4˚C. After that the sample was spun for 5 min at 13000 rpm. 200 µL of 
the top aqueous layer were transferred to a new tube and 180 µL of isopropanol + 20 
µL of 3 M sodium acetate pH 5.3 solution were added. The sample was left for 5-30 
min at -80˚C to precipitate and then spun for 15 min at 4˚C. Pellet was air dried and 
resuspended in 100 µL of H2O. 150 ng of this DNA sample were used as template 
for 50 µL PCR solutions. 
 
2.4.3 Aar2p antibody production 
Aar2p-GST was expressed in E. coli (BL21) from pGEX4T1-Aar2-GST 
plasmid (Gottschalk et al., 2001). For this the cells were induced with IPTG at a final 
concentration of 0.75 mM and grown at 23˚C for 4 h. Cells were collected spinning 
at 3500 rpm for 5 min at 4˚C. 
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Cells pellets were resuspended in lysis buffer A (50 mM Tris-HCl pH7.5; 250 
mM NaCl; 10 % (v/v) glycerol) with added lysozyme to a final concentration of 0.2 
mg/mL and the mixed on ice for 45 min. Triton-X 100 was added to a final 
concentration of 0.1% (v/v) and mixed on ice for 5 min more. The mixture was 
centrifuged at 10000 rpm for 10 min at 4˚C in a Beckman centrifuge rotor JA25.5. 
The supernatant was kept at -80˚C. 
Once thawed, the supernatant was incubated for 1h at 4˚C with 1 mL of 
Gluthatione Sepharose 4B from Amersham (previously washed in PBS). After this, 
the mixture was placed in a Biorad polyprep chromatography column. The sample 
was washed three times with wash buffer (50 mM Tris-HCl pH7.5; 250 mM NaCl; 
10 % (v/v) glycerol) and eluted from the column with elution buffer (50 mM Tris-
HCl pH7.5; 250 mM NaCl; 10 % (v/v) glycerol; 40 mM glutathione). The eluate was 
dialysed for 4 h against 2 L of dialysis buffer (20 mM Tris-HCl pH 8.0; 100 mM 
NaCl; 20% (v/v) glycerol) in a dialysis membrane (Slide-A-Lyser 7 kDa cut-off from 
Pierce). 
After dialysis the total volume of protein eluate and the corresponding protein 
band was gel purified in a denaturing protein gel. The band corresponding to Aar2p 
was excised from the gel, grinded with liquid nitrogen, resuspended in PBS and sent 
to Genosphere Biotech, Paris for rabbit inoculation. 
Immune-serum from two rabbits was obtained and tested. Serum from the 
rabbit R5725 proved to be efficient for Aar2p detection by Western blot of crude 
yeast protein extracts and was used in this study. 
 
2.4.4 λ  phosphatase assay 
 A 50 mL culture of AGY8 cells were grown to early log phase OD600=0.6 
approximately, and spun down. The pellet was resuspended in 300 µL lysis buffer 
(50 mM HEPES pH 7; 75 mM KCl; 1 mM MgCl2 10 mM EGTA; 20 mM EDTA; 
0.1% (v/v) Triton-X 100; 1 mM Na2VO4; 50 mM NaF; and for each 10 mL of lysis 
buffer, 1 mini pellet EDTA-free protease inhibitor and 1 pellet PhoSTOP, both from 
ROCHE) and 300 µL small glass beads were added. The mixture was homogenized 
in the rybolizer mixer 3 x 20 s cycles, cooling 1 min on ice between cycles. The 
lysate was clear at 13 rpm for 10 min at 4˚C. The supernatant was incubated with 20 
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µL of NiNTA agarose from QIAGEN (previously washed in lysis buffer) for 45 min 
at 4˚C. The beads were washed 3x with lysis buffer changing tubes once. The beads 
were washed once with 150 µL of λ phosphatase buffer (New England Biolabs) and 
the sample was split in half. One half was incubated with 1 µL of λ phosphatase and 
the other half was treated with buffer only for 30 min at 30˚C (50 µL reactions). The 
samples were finally spun down. The supernatant removed, the beads resuspended in 
30 µL of sample buffer and boiled at 95˚C for 15 min. At this point the samples were 
either stored at -20˚C or immediately loaded in a 12% SDS-acrylamide denaturing 
gel and ran in for 20 h at 60 V. A Western blot was preformed to transfer the bands 
to a PVDF membrane. The membrane was blocked for 1h in blocking solution (PBS-
Tween 20 0.01% (v/v); 5% (w/v) skimmed milk). After this the membrane was 
incubated o/n in blocking solution containing αAar2p (R5725) rabbit anti-serum at a 
final concentration of 1:3000. The membrane was washed 3x in PBS-Tween 20 
0.01% (v/v) and incubated for 1 h in blocking solution containing 1:10000 αrabbit 
antibody HRP conjugated The membrane was washed in PBS-Tween 20 and 
incubated with Pierce® ECL Western Blotting substrate for 2 minutes. The 
membrane was exposed to Kodak medical X-ray blue film. 
 
2.4.5 Phosphoantibodies Western blots 
Cell extracts and pulldowns were performed in the same way as in 2.4.4 with 
the exception of the λ phosphatase treatment. The samples were run in a denaturing 
gel 4-12 % PAGE gel (1x MOPS buffer) and blotted. For the αPhospho-threonine 
and αPhospho-tyrosine Western blots the membranes were blocked, and incubated 
with primary and secondary αmouse antibodies as indicated above. 10 µL of 
αPhospho-threonine was used in 5 mL of blocking solution and 50 µL of αPhospho-
tyrosine in 5 mL blocking solution. 
For the α-Phospho-serine western blot the membrane was blocked in 
PBS-Tween 20 0.01% with 5% (w/v) BSA for 1 h. After that the membrane was 
incubated o/n with 11.4 µL of αPhospho-serine antibody in 5mL of a solution 
PBS-Tween20 0.01%, 5% (w/v) BSA. The secondary αmouse antibody was 
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Immunoprecipitations were carried out binding mouse antibodies to protein G 
Dynabeads (Invitrogen) and rabbit antibodies to protein A Dynabeads according to 
manufacturer instructions. 10 µL of Dynabeads conjugated with 4 µL of antiserum 
antibody were used to immunoprecipitated each sample. 
Cell extracts were prepared as follow. 60 ODs of cells in log phase were used 
for experiments in Figures 4.6B and 4.7; 120 ODs for experiments in Figures 4.8, 5.3 
and 5.4. Cells were spun down at 4000 rpm for 10 min at 4˚C; washed in 10 mL cold 
PBS; spun down at again at 4000 rpm for 5 min at 4˚C. All the PBS was carefully 
removed and the cell pellets were snap frozen in liquid nitrogen. The samples were 
then kept at -80˚C until needed. 
Cell pellets (both 60 and 120 ODs) were thawed on ice and resuspended in 700 
µL of lysis buffer (50 mM HEPES pH 7.5; 100 mM NaCl; 1 mM MgCl2; 0.3% (v/v) 
Triton X-100; 1 mM DTT; for 20 mL of buffer 1 pellet EDTA-free protease inhibitor 
and 1 pellet PhoSTOP, both from ROCHE, were added). 300 µL of zirconia beads 
were added and the mixture was vortexed 3x1 min, resting on ice for 1 min between 
each vortex. The extracts were spun at 4000 rpm for 5 min at 4˚C. The supernatant 
was transferred to a clean eppendorf tube and spun at 14000 rpm for 20 minutes at 
4˚C. The top layer was transferred to a new eppendorf and used immediately for the 
immunoprecipitations (1-2% of this input lysate was kept for further analysis; 10% 
for experiment 5.4). The lysate was mixed with the Dynabeads previously bound to 
antibody and incubated in a rotating wheel at 4˚C. This incubation step was carried 
out for 45 min in the experiments from Figures 4.6B and 4.7. For the experiments in 
Figures 4.8, 5.3 and 5.4 the extracts were incubated with the beads for 3 h. After this 
the tubes were placed in a magnet, the non-bound fraction was removed and 2% of 
this solution was kept for further analysis (the non-bound fraction was not kept for 
experiment 5.4). The beads were washed 3x with 200 µL of cold PBS 0.02% Tween 
20. 100 µL of the same PBS solution was added to the tubes and the samples were 
transferred to a clean eppendorf. The tubes were finally placed in the magnet, the 
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supernatant removed and the beads resuspended in 20 µL of sample buffer. At this 
point the samples were either stored at -20˚C or boiled at 95˚C for 10 min, loaded in 
a denaturing 4-12% PAGE (1x MOPS buffer was used) gel together with the 2% 
input and 2% non-bound fractions for Western blot. 
For the experiments illustrated in Figure 4.6B the immunoprecipitations were 
done using mouse αLexA. Western blot was performed as described above using 
rabbit αHA and rabbit αPrp8p 8.6 simultaneously as primary antibodies at a 
concentration of 1:3000. As a secondary antibody sheep αrabbit HRP conjugated 
was used at a concentration of 1:10000. 
The immunoprecipitation in Figure 4.7 was done with mouse αHA and the 
Western blot with rabbit αLexA and rabbit αBrr2p simultaneously as primary 
antibodies at a concentration of 1:3000. As secondary antibody fluorescent goat 
αrabbit was used at a concentration of 1:10000. 
For the immunoprecipitations in Figures 4.8, 5.3 and 5.4 rabbit αAar2p 
(Gottschalk et al., 2001) serum was used, since αAar2p serum raised from this study 






Figure 2.1. Gottschalk et al., 2001 αAar2p antibody pulls down Prp8p in Aar2p 
immunoprecipitation, but my αAar2p antibody does not. Cell extracts from W303 yeast 
strain were immunoprecipitated in parallel with my αAar2p and Gottschalk et al., 2001 
rabbit serums. Rabbit αPrp8p antibody was used for the Western blot. The Gottschalk et al., 
2001 antibody efficiently pulls down Prp8p while the antibody raised by this study does not. 
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It is not possible to show Aar2p western for this experiment since Aar2p is 42 
kDa, and therefore will be masked by the IgG heavy chain. 
For the Western blots in Figures 2.1, 4.8 and 5.3 a non-protein blocking buffer 
has to be used to reduce the high background. Protein-Free (TBS) Blocking Buffer 
from Thermo scientific was used both for blocking the membrane and for incubation 
with the primary and secondary antibodies. As primary antibody αPrp8p antiserum 
was used at 1:3000 dilution. For Figure 2.1 sheep αrabbit HRP was used as 
secondary antibody at 1:10000 dilution. For Figures 4.8 and 5.3 fluorescent goat 
αrabbit was used as secondary antibody at a 1:10000 dilution. 
 
2.4.7 Northern blot 
For the Northern blot in Figure 5.4, RNA was extracted from the beads after 
immunoprecipitation, from the input and non-bound fractions. 
The beads were washed 2x with IPP150. After that 200 µL of RNA extraction 
buffer (50 mM Tris pH 7.5; 2% (w/v) SDS; 5 mM EDTA) together with 200 µL of 
phenol-chloroform iso-amyl alcohol (25:24:1) was added to the washed beads and 
input samples. The samples were vortexed and spun down at 14000 rpm for 5 min at 
RT. The top aqueous layer was kept and mixed with 200 µL NaAc 3M pH 5.3 plus 1 
µL glycogen and 400 µL ethanol. The RNA was left to precipitate for 20 min to o/n 
at -20˚C. After this step the samples were spun at 14000 for 30 min at 4˚C. The 
pellets were washed with ethanol 70% and dried. Finally the samples were 
resuspended in 10 µL H2O plus 10 µL formamide loading buffer (formamide; 0.1 M 
EDTA; trace amounts of bromophenol blue and xylene cyanol), boiled at 95˚C for 3 
min, cooled on ice and loaded in an acrylamide gel (Sequagel mixture 6% prepared 
according to manufacturer instructions) and ran at 23 W for approximately 1 h in 1x 
TBE. 
The RNA was transferred to a Hybond-N nylon membrane at 60 V for 1 h in 
0.5x TBE. The RNA was then cross-linked to the membrane in a UV crosslinker. 
The membrane was pre-incubated for 30 min at 37˚C in 50 ml Church buffer. 
Then 50 µL of U5 probe were added and let to incubate o/n (see U5 probe 
preparation bellow). After that was the membrane was washed in 6x SSC buffer for 
10 min at 37˚C; and washed again in 2x SSC for 10 min at 37 ˚C. Finally the 
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membrane was exposed to autoradiographic film to visualize the results and to 
phosphor screen for quantification in the PhosphorImager. 
For the U5 probe preparation were mixed: 0.5 µL of 10 µM U5 
oligonucleotide; 1 µL 10x PNK buffer; 5.5 µL H2O; 2 µL [γ-32P]ATP (3000 
Ci/mmol) and 1 µL kinase T4 polynucleotide (PNK). The reaction was left at 37˚C 
for 1 h and then incubated at 65˚C for 5 min to inactivate the kinase. Finally were 
added 40 µL H2O and the mixture was purified in a spin purification column. 
 
2.4.8 Sample preparation for mass spectrometry 
Yeast extracts from PGAL1-AAR2-His strain grown in 2% galactose were 
prepared and a pulldown with NiNTA beads was made as explained above. Samples 
were run in a denaturing acrylamide 4-12% PAGE gradient gel and the gel stained 
for 1 h with Coomassie Brilliant Blue R250 from Pierce (Thermo Scientific). In-gel 
digests with trypsin, elastase, proteinase K, and thermolysin were performed 
independently according to Schlosser et al. (2005) plus 10 µL of acetonitrile in a 
final digestion volume of 100 µL. 
 
2.5 Live cell imaging 
Strains AGY8, VCY1 and VCY2 were grown overnight in 2% galactose. In the 
morning the strains were diluted to OD600=0.2 and grown in 2% galactose and 2 % 
glucose in parallel for 8h in log phase. 50 µL of each cell culture were spin down and 
resuspended in 150 µL of fresh media. From here 50 µL were spread on a poly-
lysine coated microscope slide (Polysine, VWR, 631-0107) together with mounting 
solution containing DAPI. Prp8p-GFP and Snu114p-GFP localisation was verified 
on live cells by fluorescence microscopy with a Leica FW4000 microscope, 100x 
magnification. This microscope is equipped with a narrowband filter wheel that 
detects GFP and DAPI fluorescence (gfp - 489 nm excitation and 508 emission; A4 - 
354 nm excitation and 461 emission). Regarding the exposure times, these were 200 
to 500 milliseconds to GFP and 50 to 100 milliseconds for DAPI. Because live cells 
are constantly moving only one z-section was recorded for each snapshot. A 
CoolSNAP camera (Roper Scientific) with Leica FW4000 V1.1.1 software was used 
to capture the images. 
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2.6 Yeast two-hybrid (Y2H) assay and screens 
Both Y2H assay and screen were performed according to Fromont-Racine et 
al. (2002). 
In the Y2H assay Aar2p full-length, Aar2p1-170 and Aar2p150-355 were cloned in 
pBTM116-1 plasmid and used as baits. Prp8p1649-2413, Prp8p2010-2413 and 
Prp8p2010-2413-prp8-52 fragments previously cloned in pACTII-stop vector (van Nues 
and Beggs, 2001) were used as preys. 
For the Y2H screens the Aar2p1-170 and Aar2p150-355 fragments already cloned 
in pBTM116-1 plasmid were used as baits against a S. cerevisiae prey library from J. 
C. Rain, Hybrigenics, Paris. 
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CHAPTER 3 - Aar2p phosphorylation 
 
3.1 Introduction 
A question emerging from the proposed U5 snRNP maturation model (Boon et 
al., 2007) concerns the mechanism that triggers Aar2p release from the precursor 
U5-snRNP (see Figure 1.5). If Aar2p and Brr2p compete for binding to Prp8p, there 
must be a signal leading to Aar2p departure from the U5 snRNP, thereby allowing 
Brr2p to bind Prp8p as one of the required steps for U5 snRNP maturation. One 
possibility is a post-translational modification that elicits Aar2p release from the U5 
snRNP. A common post-translational modification is phosphorylation (Cohen, 
2000). In fact, several of the conformational rearrangements that occur during the 
splicing reaction are controlled by phosphorylation and dephosphorylation events 
(Misteli, 1999). For example, the PP1/PP2A phosphatases elicit transition from first 
to second step of splicing having SAP155 and U5-116kDa as major substrates in 
human spliceosomes (Shi et al., 2006). Another relevant event that requires 
phosphorylation is the integration of the tri-snRNP into the human spliceosome due 
to PRP28 phosphorylation (Mathew et al., 2008). Still in humans, the tri-snRNP 
proteins PRP6 and PRP31 are phosphorylated by PRP4 kinase during spliceosomal 
complex B formation (Schneider et al., 2010). Accordingly, it is plausible that a 
phosphorylation/dephosphorylation event might also regulate Aar2p interaction with 
the U5 snRNP. 
Following this hypothesis I investigate the phosphorylation state of Aar2p. All 
the assays described in this chapter are performed with yeast strain AGY8 
(Gottschalk et al., 2001) kindly provided by P. Fabrizio. In this strain, the genomic 
AAR2 is disrupted by insertion of URA3 as a marker and it carries a plasmid that 
produces Aar2p with histidine tag under control of the GAL1 promoter.  
This study shows for the first time that Aar2p is indeed phosphorylated and it 
identifies five phosphorylated aminoacids: S253, T274, Y328, S331 and T345. 
 
3.2 λ  phosphatase assays 
The first experiment carried out is a band mobility shift assay after incubation 
in the presence or absence of λ phosphatase. This enzyme dephosphorylates 
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phosphorylated serines, threonines and tyrosines (the most frequently phosphorylated 
amino acids in eukaryotes) in a Mn2+-dependent way (Zhuo et al., 1993). If Aar2p is 
phosphorylated in any of these residues the phosphatase will release the phosphate 
groups. Under these conditions, the dephosphorylated Aar2p will migrate faster in a 
denaturing gel than non-treated Aar2p. Cell extracts were prepared from the AGY8 
strain (PGAL1-AAR2-his6) grown on 0.3%, 0.5% or 2% (w/v) galactose plus 3.7%, 
3.5% and 2% (w/v) raffinose respectively in order to produce cell extracts containing 
different amounts of Aar2p. A pulldown with Ni-NTA beads was done. Half of each 
sample was treated with λ phosphatase and the other half was treated with λ 
phosphatase buffer only under the same conditions. The samples were run in a 
denaturing 12% (w/v) acrylamide gel and a Western blot was carried out, probing for 
Aar2p (Figure 3.1A). Yeast strain JF191 (kindly provided by J. Fernius) was used as 
a positive control for λ phosphatase activity and mobility shift in this experiment 
(Figure 3.1B). In this strain Spc105p, that is a subunit of a kinetochore-microtubule 
binding complex (Nekrasov et al., 2003), is Myc tagged. Spc105p is known to be 
phosphorylated at T356 and S380 (Li et al., 2007). 
Figure 3.1 shows that when samples are incubated with λ phosphatase, Aar2p 
mobility in the denaturing gel is affected. The treated samples run faster than the 
untreated ones demonstrating that Aar2p is indeed phosphorylated in vivo in budding 
yeast. 
 
3.3 Assays with phospho-specific antibodies  
Acknowledging that Aar2p is phosphorylated, the next question is which 
residue(s) is(are) phosphorylated. This can be addressed by using anti-
phosphopeptide antibodies (Sefton and Shenolikar, 2001). 
Cell extracts were prepared in the same way as for the band shift experiment, 
but without the λ phosphatase treatment. The samples were run in a denaturing gel 
and the Western blots were probed with αPhospho-serine, αPhospho-threonine or 
αPhospho-tyrosine antibodies (Figure 3.2). The results show that some serine and 
tyrosine residues of Aar2p are phosphorylated. The absence of signal detected with 
αPhospho-threonine indicates that most likely there are not phosphorylated 





Figure 3.1. Aar2p is phosphorylated in budding yeast. A) Western blot showing Aar2p 
band-shift after treatment with λ phosphatase. AGY8 cells were grown in 0.3%, 0.5% and 
2% galactose (w/v) plus 3.7%, 3.5% and 2% raffinose (w/v) respectively, and collected at 
OD600=0.6.  Cell extracts were prepared and incubated with NiNTA beads to pulldown 
Aar2p-His6. The beads-Aar2p-His6 complexes were split in two equal parts: one was 
incubated for 30 minutes with λ phosphatase, and the other half was incubated with buffer 
only. The samples were run in a denaturing 12% acrylamide gel, blotted and probed with 
anti-Aar2p antibody. All the extracts treated with λ phosphatase show a mobility shift 
(around 0.45 kDa) when compared with the non-treated ones, indicating that Aar2p is 
phosphorylated in vivo. B) Positive control Spc105p-Myc13 for band-shift experiment. The 
cells were collected and treated with λ phosphatase as described for AGY8. Pulldown was 
made with mouse αMyc antibody and the blot was probed with rabbit αMyc antibody. The 
band shift observed indicates that the conditions used for the λ phosphatase assay are 







Figure 3.2. Aar2p has phosphorylated serine(s) and tyrosine(s). Western blots showing 
Aar2p-His6 detected with αPhospho-serine and αPhospho-tyrosine antibodies. No 
Aar2p-His6 was detected with αPhospho-threonine. AGY8 cells were grown in 0.3%, 0.5% 
and 2% galactose (w/v) plus 3.7%, 3.5% and 2% raffinose (w/v) respectively, and collected 
at OD600=0.6.  Cell extracts were prepared and incubated with NiNTA beads to pulldown 
Aar2p-His6. The samples were run in a denaturing SDS-acrylamide 4-12% PAGE gel blotted 
and probed with αPhospho-Serine, αPhospho-Tyrosine and αPhospho-Threonine antibodies. 
These results imply that Aar2p has phosphorylated serine(s) and tyrosine(s) in vivo. 
 
 
3.4 Mass-spectrometry results 
Mass-spectrometry is a powerful technique in the study of post-translational 
modifications, enabling identification of phosphorylated aminoacids within a protein 
(reviewed in Salzano and Crescenzi, 2005). In order to map the exact position of the 
phosphorylated aminoacids in Aar2p, extracts from the AGY8 strain were prepared 
and analysed by mass-spectrometry. 
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Yeast extracts from AGY8 grown in 2% (w/v) galactose plus 2% (w/v) 
raffinose were prepared as described for previous experiments, and a pulldown with 
NiNTA beads was done. Samples were run in a denaturing acrylamide 4-12%  PAGE 





Figure 3.3. AGY8 extracts analysed by mass-spectrometry. Four yeast extracts (A, B, C 
and D) from AGY8 growing in 2% galactose (w/v) plus 2% raffinose (w/v) were prepared as 
before and a pulldown with NiNTA beads was made. The four bands corresponding to 
Aar2p-His6 were isolated from the gel, and each one was used for an in-gel digest with one 
of the following proteases: elastase, trypsin, proteinase K and thermolysin. The digested 
samples were sent to J. Rappsilber lab to be analysed by mass-spectrometry. 
 
 
The band corresponding to Aar2p was cut out and four protease in-gel digests 
with elastase, trypsin, proteinase K or thermolysin were performed for 16 hours at 
30ºC in NH4HCO3 pH 8 (Schlosser et al., 2005). The resulting digested peptides 
were analysed by mass-spectrometry by F. de Lima Alves in J. Rappsilber’s lab 
(Wellcome Trust Centre for Cell Biology, Edinburgh). Figure 3.4 shows the Aar2p 
peptide coverage obtained with each protease digest and the candidate 






Figure 3.4. Mass-spectrometry results. Aar2p peptide sequence coverage and 
phosphorylated peptides identified with each protease digest. The aminoacids in red 
represent the peptide coverage obtained with the indicated digestion while the ones in grey 
represent the ones not covered. The candidate phosphorylated aminoacids are indicated with 
a blue square. Trypsin digest had a sequence coverage of 97% and identified S331 and T345. 
proteinase K digest with also 97% of sequence coverage and S331 identified. 98% of 
sequence coverage was obtained with elastase digest which recognized T274, Y328, S331 
and T345 as phosphorylated sites. With thermolysin digest 99% of Aar2p sequence was 
covered and S253, Y328 and S331 were identified as phosphorylated. 
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Complete sequence coverage was obtained with the combination of enzymes 
used: trypsin 97%, proteinase K 97%, elastase 98% and thermolysin 99%. However, 
not all of the digests identified the same phosphorylated aminoacids. Trypsin 
digestion revealed S331 and T345; proteinase K digestion identified S331; elastase 
digestion uncovered the highest number of phosphorylated sites, T274, Y328, S331 
and T345; and finally S253, Y328 and S331 were revealed after thermolysin digest. 
Overall, five phosphorylated sites were identified in Aar2p: S253, T274, Y328, S331 
and T345. 
These results are in agreement with my α-Phospho-serine and α-Phospho-
tyrosine western blots that show the presence of phospho-serines and tyrosines in 
Aar2p. The α-Phospho-threonine western indicates that there are no phosphorylated 
threonines, whereas the mass-spectrometry analysis identifies two, T274 and T345. 
This discrepancy can be due to a low sensitivity of the α-Phospho-threonine 
antibody compared to the mass-spectrometry analysis. Another plausible explanation 
is that mass spectrometry, not being quantitative in the conditions used, detected a 
very minor fraction of Aar2p not detectable by western blot analysis. 
 
3.5 Aar2p sequence alignment 
To determine if any of the phosphorylated amino acids identified is conserved 
across eukaryotes, I did a multiple sequence alignment of Aar2p orthologs in 
different species. Amino acid sequences of Aar2p were retrieved from Genbank for 
Saccharomyces cerevisiae and other species including Homo sapiens. The sequences 
were then aligned in Jalview 2.5 (Waterhouse et al., 2009) using the MUSCLE 
alignment algorithm (Edgar, 2004) (Figure 3.5). The five phosphorylated aminoacids 
identified by mass-spectrometry in S. cerevisiae are highlighted in Figure 3.5 with a 
red asterisk. S253 is conserved in almost all of the species, including in humans, with 
the exception of Arabidopsis thaliana, Caenorhabditis elegans, and Xenopus laevis. 
On the other hand, none of the remaining phosphorylated sites is conserved across 
the species compared. These results suggest that only phosphorylation of S253 might 


























































































































Figure 3.5. Multiple sequence alignment of Aar2p homologs in different species. 
Aminoacid sequences of Aar2p were retrieved from Genbank for representative fungal, plant 
and animal taxa. Sequences were aligned in Jalview 2.5 (Waterhouse et al., 2009) using 
MUSCLE alignment algorithm (Edgar, 2004) as this method tends to be more accurate than 
ClustalW when dealing with a diverse set of sequences. Each aminoacid is assigned a colour 
if it meets a conservation threshold. Colours represent a combination of this threshold with 
residue group type-specific criteria. 
The five phosphorylated aminoacids identified by mass-spectrometry in S. cerevisiae are 
highlighted here with a red asterisk. S253 shows the highest aminoacid conservation among 
the phosphorylated sites, suggesting its hypothetical signaling function might be conserved 




Using a set of complementary techniques I confirm that Aar2p is 
phosphorylated in vivo in Saccharomyces cerevisiae and identify five phosphorylated 
aminoacids: S253, T274, Y328, S331 and T345. Supporting these data, a 
phosphoproteome study identified Aar2p S331 to be phosphorylated in S.cerevisiae 
after DNA-damage induction by genotoxic stress with methyl methanesulfonate 
(Albuquerque et al, 2008). This is an allusion to a new putative role for Aar2p 
besides its involvement in pre-mRNA splicing. It is possible that Aar2p is required 
for a stress-related response and phosphorylation of S331 might play a role in this 
mechanism. Since S331 is not conserved in any other species this could be a feature 
exclusive to S. cerevisiae. 
Comparison of Aar2p orthologues suggests that S253 is conserved across 
several eukaryotes, including in humans, suggesting its function could be conserved 
throughout evolution. Hence it is possible that the phosphorylation state of S253 
controls Aar2p activity and/or regulates its interaction with other proteins. 
This study suggests that a phosphorylation/dephosphorylation event can have a 
role in U5 snRNP maturation, likely triggering Aar2p release from the precursor 
form of U5-snRNP. Subsequently, this would allow Brr2p to bind Prp8p, completing 
the maturation process. Due to its conservation, S253 is the most likely Aar2p 
phosphorylated amino acid to play a role in U5 snRNP maturation. 
Further work is required to clarify which kinase is responsible for Aar2p 
phosphorylation and to disclose the functional importance of each of the five 
phosphorylated aminoacids. 
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CHAPTER 4 – Aar2p/Prp8p interaction 
 
4.1. Introduction 
Several clues exist for a physical interaction between Aar2p and components of 
the intermediate U5 snRNP, particularly with Prp8p (Gottschalk et al., 2001; Gavin 
et al., 2002; Gavin et al., 2006; Boon et al, 2006; Collins et al., 2007; Boon et al, 
2007). It was observed that Prp8p fragmentation at Prp8p2173 interferes with Prp8p 
association with Aar2p. Also, the amount of Aar2p associated with Prp8p771-2413 was 
increased compared to the full-length Prp8p (Boon et al, 2006). Although it is 
generally believed that Aar2p interacts with C-terminal Prp8p (Boon et al., 2006; 
Boon et al, 2007), a direct interaction was never demonstrated and the exact region 
of interaction required is not known for either Prp8p or Aar2p. 
Kutach (unpublished data – personal communication) purified yeast 
Prp8p1806-2413, which he termed Prp8p-CTF, and identified one co-purifying protein - 
Aar2p. He obtained a Prp8p/Aar2p/Brr2p complex from a mixture of Aar2p, Brr2p 
and Prp8p-CTF in vitro. From his observations, binding of Brr2p to Prp8p-CTF does 
not inhibit the subsequent interaction of Aar2p with Prp8p-CTF, however, pre-
binding an excess of Aar2p to CTF inhibits subsequent binding of Brr2p. He 
suggests that Aar2p binds to CTF-N and clamps down the CTF-C, impairing Brr2 
binding to this region. 
In this chapter I look into Aar2p interaction with Prp8p. I show here that Aar2p 
does not contribute to Prp8p and Snu114p nuclear import and that Aar2p1-170 
interacts with Prp8p1649-2413 in Y2H and in pull-down assays. In addition I discover 
that the Aar2p mutation S253E strongly disrupts the Aar2p/Prp8p interaction. Finally 
I discard any potential role of Prr2p and Gcn2 kinases might have in the regulation of 
Aar2p/Prp8p interaction.  
 
4.2. Localisation experiments 
It is known that Prp8p’s NLS has a role in Prp8p nuclear import (Boon et al., 
2007). It is possible however that Aar2p can be an additional cofactor in this process, 
helping the nuclear import of Prp8p and other components of the Aar2p-U5 particle, 
such as Snu114p. Using the AGY8 strain as a base I created two new strains: one 
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expressing PRP8-GFP - strain VCY1; and another expressing SNU114-GFP - strain 
VCY2. When growing the cells in decreasing galactose concentrations the 






Figure 4.1. Aar2p-His6 production decreases with decrease in galactose concentration 
in the AGY8 strain. A) AGY8 cells were grown in 2%, 0.5%, 0.4%, 0.3%, 0.2% and 0.1%, 
galactose (w/v) plus 2%, 3.5%, 3.6%, 3.7%, 3.8% and 3.9% raffinose (w/v) respectively. 
Cell extracts were run in a denaturing gel, blotted and probed with αAar2p antibody. B) The 
same extracts as in A) run in a different gel and blotted with αHis antibody. 
 
 
Hence, switching off AAR2 expression by growing the cells on glucose, allows 
the role of Aar2p in Prp8p and Snu114p import into the nucleus to be examined. 
Strains AGY8, VCY1 and VCY2 were grown in 2% galactose and 2% glucose in 
parallel and Prp8p-GFP and Snu114p-GFP localisation in live cells was investigated 
by fluorescence microscopy. In Figure 4.2 is clear that both Snu114p and Prp8p are 
predominantly nuclear either with AAR2 overexpression or repression. Thus, Aar2p 







Figure 4.2. Aar2p does not affect GFP-Prp8p and GFP-Snu114p localisation. Strains 
AGY8, VCY1 and VCY2 were grown on 2% glucose (AAR2 repression) and on 2% 
galactose (AAR2 overexpression) and observed by fluorescence microscopy. The cells were 
mounted on glass slides with DAPI to stain the nuclear DNA. The non-tagged control strain 
(AGY8) shows some auto-fluorescence. It is clear that the nuclear localisation of GFP-Prp8p 
and GFP-Snu114p in the VCY1 and VCY2 strains is unaffected regardless of the AAR2 
expression level. Both VCY1 and VCY2 strains show more fluorescence in the cytoplasm 
than the AGY8 strain, possibly due to higher levels of GFP-Prp8p and GFP-Snu114p in the 
cytoplasm. Scale bar corresponds to 10 µm. 
 
 
4.3. Yeast two-hybrid assays 
A yeast two-hybrid  (Y2H) assay was set up to investigate the Aar2p/Prp8p 
interaction in detail. Full-length Aar2p, Aar2p1-170 and Aar2p150-355 were used as bait 
fusions (with a LexA tag) and Prp8p1649-2413 (E1), Prp8p2010-2413 (E3) and Prp8p2010-
2413-prp8-52 (Y2037H, I2051T-located in domain IV; E3H) as prey fusions (with an 







Figure 4.3. Schematic representation of the protein fragments used for Y2H assays. In 
this work, all full length and partial Aar2p fragments were cloned into the pBTM116-1 
vector to be used as baits. The Prp8p fragments were previously cloned (van Nues et al., 
2001) into the pACTII-stop vector as prey fusions. The E3H fragment differs from E3 in two 
point mutations (indicated by ), Y2037H and I2051T, the same as in the prp8p-52 mutant. 
Please note that the figure is not to scale. 
 
 
Prp8p2010-2413-prp8-52 was previously reported (van Nues & Beggs, 2001) as 
having an increased binding affinity to Brr2p when compared to Prp8p2010-2413 in a 
yeast two-hybrid assay. The interactions were tested at 18, 25, 30 and 33°C with 1, 5, 
10, 25 and 50 mM of 3AT (Figure 4.4). Full-length Aar2p shows auto-activation 
activity, since the strain that contains Aar2p as bait plus pActII empty vector grows 
in -LWH and in -LWH supplemented with 3AT. This fact limits the conclusions that 
can be drawn from the assays where full-length Aar2p was used as bait. Nevertheless 
two remarkable conclusions can be made from this experiment. The first is a 
cold-sensitive (cs) growth phenotype when the Aar2p full-length bait is combined 
with the E3H fragment (Prp8p2010-2413-prp8-52) as a prey. The second is the fact that 
Aar2p1-170 interacts with E1 (Prp8p1649-2413), E3 (Prp8p2010-2413) and E3H 
(Prp8p2010-2413-prp8-52). Although this interaction does not seem very strong (the 
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cells cannot survive at high 3AT concentrations), it is possible to conclude that 
Aar2p1-170 interacts with C-terminal Prp8p. 
The next step was to mutate the Aar2p phosphorylation sites described in 
Chapter 3, and search for an effect on Aar2p/Prp8p interaction. Accordingly, the 
full-length Aar2p bait was subjected to site-directed mutagenesis (SDM) in order to 
individually mutate S253, T274, Y328, S331 and T345 to Alanine (A) or Glutamic 
acid (E). This mimics the effect of non-phosphorylated (Alanine) and phosphorylated 
(Glutamic acid) aminoacid residues in the Aar2p/Prp8p interaction in the Y2H 
system. 
In this Y2H spotting assay all the phosphomutants auto-activate, growing in 
-LWH plates when in combination with empty pActII vector, just like the wt Aar2p 
bait fusion (data not shown). Yet several important observations can be made. Some 
of the phosphomutants show cs growth phenotypes when in combination with the E3 
and E3H Prp8p fusions (similar to wt Aar2p), while others rescue the growth 
phenotype (Figure 4.5). The low temperature exacerbates the defect in the majority 
of the mutants with exception of T274A, Y328A, T345A and T345E. Mutations 
S253A, T274E, Y328E, S331A and S331E behave like wt when in combination with 
E3 and E3H fragments. When growth defects are observed, they are stronger if the 
mutations are combined with the E3H than with the E3. On the other hand, high 
temperatures aggravate the growth defect on the T274E, Y328E, S331A and S331E 
mutants. Five mutants rescue the wt growth phenotype at 18, 25 and 33°C: S253E 





Figure 4.4. Aar2p1-170 interacts with Prp8p fragments E1, E3 and E3H. Y2H spotting 
assay shows cells growing at 18, 25 and 33˚C. Cells were plated on -LW, -LWH and -LWH 
supplemented with different 3AT concentrations (1, 5, 10 25 and 50 mM). It is not possible 
to conclude about the interaction of full length Aar2p with the Prp8p fragments since the 
negative control (Aar2p full length + pActII empty vector) auto-activates and grows in non-
permissive conditions. Aar2p150-355 does not interact with any of the Prp8p fragments tested 








Figure 4.5. Aar2p phospho mutations confer growth defects when in combination with E3 and E3H Prp8p fragments. 
(See legend on page 58) 57 
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Figure 4.5. Aar2p phospho mutations confer growth defects when in combination with 
E3 and E3H Prp8p fragments. Cells were plated on -LW and grown at different 
temperatures. No growth defects were observed when combining the mutations with E1 or 
empty pActII vector. Auto-activation of pActII is also observed in -LWH plates (not shown). 
Some of the phospho mutations cause stronger growth defects than seen with the wt whereas 





4.4. Aar2p/Prp8p Co-Immunoprecipitation 
Due to the observed auto-activation of Aar2p and its phosphomutants, an 
alternative way to test for Aar2p/Prp8p interaction is to perform 
immunoprecipitations of the Aar2p-LexA wild type and mutant fusion proteins and 
compare the amount of Prp8p-HA E1 fragment co-precipitated (Figure 4.6). After 
confirming that all the Aar2p fusion proteins had similar expression levels (Figure 
4.6A) the immunoprecipitations were carried out in all the strains with mouse αLexA 
antibody coupled to protein G Dynabeads. This was followed by a rabbit αHA + 
rabbit αPrp8p Western blot to probe for the Prp8p-HA E1 fragment and the 
endogenous Prp8p simultaneously (Figure 4.6B). These results show that mutating 
Aar2p S253 to Glutamic acid disrupts Aar2p/Prp8p interaction both with Prp8 E1 
fragment and with endogenous Prp8p. None of the other mutations affects the 
amount of Prp8p pulled down by Aar2p. 
Bearing in mind the immunoprecipitation results (Figure 4.6) together with the 
fact that all the phosphomutants, wt Aar2p and the Prp8p fragments are being 
overproduced, a rather straightforward explanation can be found for the growth 
phenotypes. The overproduced proteins will imbalance the cellular 
Aar2p/Prp8p/Brr2p equilibrium since E3 and E3H fragments have high affinity for 
Brr2p, being able to deviate it from the interaction with endogenous Prp8p. In 
addition, the overexpressed wt Aar2p and Aar2p-S253A will bind to endogenous 
Prp8p, exacerbating the effect caused by the E3 and E3H overexpression in the cell. 
On the other side Aar2p-S253E is not able to bind Prp8p efficiently, relieving the 
stress caused by its overexpression. As a consequence, Aar2p-S253E can partially 





Figure 4.6. Aar2p S253E mutation disrupts Aar2p/Prp8p interaction. Cell extracts were 
prepared and immunoprecipitation with protein G dynabeads bound to mouse αLexA was 
performed. A) 2% of the input was run in a gel and the Western blot was probed with rabbit 
α LexA. This shows that Aar2p-LexA expression level is the same in wt Aar2p and in all the 
phospho mutants. B). 2% of the input and the pulldown totals were run in a gel and the 
Western blot was probed with rabbit αHA and rabbit αPrp8p simultaneously. 
 
 
To test this argument a series of Prp8p-HA immunoprecipitations were 
performed, followed by a Western blot with rabbit αLexA + rabbit αBrr2p. If the 
above explanation is correct more Brr2p is expected to be pulled down by the E3 and 
E3H Prp8p fragments than by E1. Also, when Aar2p S253 is mutated to a Glutamic 
acid (consequently less Aar2p bound to Prp8p and Prp8p-HA) the amount of Brr2p 
pulled down by Prp8p-HA should increase. However that is not observed in Figure 
4.7. There is no increase on Brr2p level pulled down neither by E3 or E3H nor with 
the Aar2p S253E mutation. In fact there is no detectable amount of pulled down 
Brr2p, it is only visible on the input lanes. However, this experiment shows that only 






Figure 4.7. Aar2p interacts with E1 Prp8p fragment, but not with E3 and E3H. Cell 
extracts were prepared and the Prp8p fragments were immunoprecipitated with protein G 
dynabeads bound to mouse αHA. 2% of the input was run in a gel and the Western blot was 
probed with rabbit αLexA and rabbit αBrr2p simultaneously. E1 is the only Prp8p fragment 
that pulls down Aar2p-LexA and Aar2p-S253A-LexA. None of Prp8p fragments pulls down 
Brr2p, contrary to the expected. 
 
 
4.5. Aar2p/Prp8p interaction regulation – two putative kinases 
After showing that the Aar2p S253 phospho-mimic mutation inhibits the 
Aar2p/Prp8p interaction, two candidate kinases were revealed as putative interaction 
regulators: Prr2p and Gcn2p. Aar2p, Lsm12p and Prp40p were previously 
recognized as in vitro substrates for Prr2p kinase (Ptacek et al., 2005), and Gcn2p 
was identified as a physical interactor of Aar2p, Brr2p, Prp4p, Prp6p, Prp8p, Prp31p, 
Snu66p and Snu114p by a genome-wide screen (Gavin et al., 2002; Gavin et al., 
2006). 
I got the prr2Δ and gcn2Δ yeast strains from the EUROSCARF deletion 
collection and compared the level of Prp8p pulled down by Aar2p in these two 
strains and in wild type. I first optimized the immunoprecipitation and Western blot 
conditions since neither Aar2p nor Prp8p was tagged in these strains. Hence rabbit 
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αAar2p serum had to be used for the immunoprecipitation and rabbit αPrp8p serum 
was used for the Western blot. 
Figure 4.8 exhibits Aar2p immunoprecipitation from BY4741, 
BY4741-ΔPRR2 and BY4741-ΔGCN2 yeast cell extracts followed by αPrp8p 
Western blot. The LI-COR Odyssey imaging system was used in order to quantify 
the amount Prp8p pulled down in each gel lane. As the values demonstrate in the 
table (Figure 4.8), the amount of Prp8p pulled down is very similar in all strains, 







Figure 4.8. Neither Prr2p nor Gcn2p kinases regulates the Aar2p/Prp8p interaction. 
Aar2p immunoprecipitations were carried out on wt (BY4741) and ∆ kinase strains 
(BY4741-∆PRR2 and BY4741-∆GCN2) followed by a Western blot probed with αPrp8p 
antibody. In order to quantify the amount of Prp8p pulled down in each lane with the LI-
COR Odyssey system, a fluorescent αrabbit secondary antibody was used. The table lists the 
fluorescence intensity registered for each Western blot lane and the ratios pulldown/input 
and pulldown/non-bound for each of the strains. The white part of the table shows the results 
of the experiment illustrated in the figure. The yellow part of the table shows the values 
obtained with a biological replicate of this experiment. The BY4741-∆PRR2 ratio 
pulldown/input suggests that the absence of Prr2p might favour the Aar2p/Prp8p interaction, 
however the ratio pulldown/non-bound in both experiments shows that Prr2p absence is 
irrelevant for Aar2p/Prp8p interaction. The green part of the table shows the values for an 
experiment done with the BY4741 and BY4741-∆PRR2 strains only. From the last 
strain input pulldown non-bound pulldown/input
BY4741 0.9 0.42 1.56 0.47
BY4741-!PRR2 0.44 0.41 1.55 0.93
BY4741-!GCN2 0.99 0.55 2.54 0.56
BY4741 0.62 0.28 1.54 0.45
BY4741-!PRR2 0.09 0.17 0.95 1.89
BY4741-!GCN2 0.16 0.14 1.22 0.88
BY4741 0.87 1.06 0.7 1.22












experiment ∆PRR2 seems to have the opposite effect from the previous two experiments. 
Thus from this data it is not possible to conclude that Prr2p is a regulator of the Prp8p/Aar2p 
interaction. 
 
Looking at the ratio pulldown/input from the BY4741-∆PRR2 strain in the first 
two experiments it gives a suggestion that Prr2p has a weak effect on the Aar2/Prp8p 
interaction. On the other hand, the ratio pulldown/non-bound does not indicate any 
difference from BY4741. If we look at the values of the third experiment, ∆PRR2 
shows the opposite effect on the Prp8p/Aar2p interaction. The slight discrepancy in 
the results can be due to common experimental variability, such as pippeting and 
Western transfer efficiency. This, added to the fact that the Aar2p/Prp8p binding 
efficiency is very low, leading to relatively large fluctuations in the calculated ratios, 
makes it difficult to acknowledge if there is really an Aar2p/Prp8p binding effect in 
the BY4741-∆PRR2 strain. A large number of experiments would be necessary to 




Novel and interesting results are presented in this chapter. It is revealed that 
Aar2p interacts with Prp8p1649-2413 (Figure 4.7) and also that Aar2p S253E mutation 
abolishes the Aar2p/Prp8p interaction (Figure 4.6). 
From the information gathered here it is possible to divide Aar2p in two 
functional halves. The N-terminal half is the Prp8p interacting domain and the C-
terminal half regulates the interaction through Aar2p phosphorylation state. The 
results suggest that Prp8p interacts with Aar2p in its non-phosphorylated form and 
once S253 is phosphorylated the interaction is reduced or abolished. This fits the 
proposed U5 snRNP maturation model (Boon et al., 2007) in which after the U5 
precursor complex enters the nucleus, Aar2p is replaced with Brr2p on the Prp8p C-
terminus interacting region. The same authors suggest that Aar2p and Brr2p compete 
for the interaction with Prp8p, and that Aar2p might function as a chaperone 
preventing Brr2p from binding to Prp8p earlier than required for splicing to occur. 
My data help to sustain this model since S253 phosphorylation seems to be a 
mechanism by which the Aar2p/Prp8p interaction is disrupted, allowing Brr2p to 
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bind the Prp8p C-terminus. Also, I discard a possible role that Aar2p might have on 
nuclear import of Prp8p and Snu114p (Figure 4.2), reinforcing the idea that Aar2p 
can be in fact a Prp8p chaperone for the Brr2p interaction. 
Puzzling results were obtained with the phosphomutants spotting assays 
(Figure 4.5). A series of growth defects were observed when wt Aar2p and some 
phosphomutations were combined with E3 and E3H Prp8p fragments, while other 
phosphomutations rescued the phenotype obtained with wt Aar2p. If the 
Prp8p/Aar2p/Brr2p mutually exclusive model is correct (Boon et al., 2007; Kutach, 
unpublished data), the growth phenotypes can be explained by a competition 
between endogenous Prp8p and the Prp8p-HA fragments to bind endogenous Brr2p. 
Since the E3 and E3H Prp8p fragments have high affinity for Brr2p (in particular 
E3H), they will sequester it from its interaction with endogenous Prp8p. This 
imbalance is exacerbated by the overexpression of Aar2p-LexA that in turn binds to 
endogenous Prp8p. All of this disturbs the cellular equilibrium between precursor 
(Aar2p/Prp8p-containing) and mature (Brr2p/Prp8p-containing) U5 snRNP forms, 
most likely affecting vital splicing levels and leading to growth defects. 
The S253A mutation causes a cs growth phenotype very similar to wt both at 
18˚C and 25˚C while S253E partially rescues it. Such effect was foreseeable since 
Aar2p-S253A binds to Prp8p with the same efficiency as the wt while Aar2p-S253E 
does not (Figure 4.6). According to the experiment illustrated in Figure 4.6 all the 
other phosphomutants bind to Prp8p similarly to wt Aar2p, so growth phenotypes are 
expected when combining any of these mutant proteins with E3 or E3H in the cells. 
It is therefore surprising to observe that T274A, Y328A, T345A and T345E can 
rescue the wt+E3H phenotype at all temperatures. On the other hand T274A, T274E, 
Y328A and Y328E show stronger growth defects than wt when combined with E3 at 
18˚C. Also interesting are the S331A/S331E mutations +E3 and +E3H at 18˚C 
causing growth defects stronger than the wt. Finally, S331+E3H at 33˚C results in a 
growth defect more serious than with wt Aar2p. Either T274, Y328, S331 and T345 
phosphomutations indirectly affect the Aar2p/Prp8p/Brr2p equilibrium perturbing 
pre-mRNA splicing, or they distress other cellular processes that have a cumulative 
effect with E3 and E3H over expression. S331 was previously described as being 
phosphorylated as a result of DNA damage (Albuquerque et al, 2008). Therefore, the 
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effect observed with S331A/S331E might be due to disruption of the cell stress 
response. 
Brr2p was shown previously to bind E1, E3 and E3H Prp8p fragments by Y2H 
assay (van Nues & Beggs, 2001), however when I did the Prp8p-HA 
immunoprecipitations (Figure 4.7) I do not detect Brr2p being pulled down by any of 
the Prp8p-HA fragments. A similar situation happened with Aar2p. From the first 
Y2H assay (Figure 4.4) I observed that Aar2p1-170-LexA interacts with all the Prp8p-
HA fragments E1, E3 and E3H. Although from the Prp8p-HA immunoprecipitations 
(Figure 4.7), only E1 pulled down full-length Aar2p-LexA. This can be due to either 
the interactions not being stable in the conditions used for the immunoprecipitations 
or the Prp8p-HA fragments pulldown such a low level of Brr2p and Aar2p-LexA that 
the proteins cannot be detected by the Western blot. 
Known candidate kinases for regulation of Aar2p/Prp8 interaction through 
S253 phosphorylation are Prr2p and Gcn2p, since Prr2p was found to phosphorylate 
Aar2p in vitro (Ptacek et al., 2005) and Gcn2p was isolated in a complex with Aar2p 
and other U5 snRNP and tri-snRNP proteins (Gavin et al., 2006). However, the role 
of Prr2p and Gcn2p kinases in controlling Aar2p/Prp8p interaction was not 
supported by immunoprecipitation assays (Figure 4.8). 
Prr2p - Pheromone Response Regulator 2 (Burchett et al., 2001) - is a 
serine/threonine kinase that inhibits pheromone induced signaling downstream of 
MAPK, probably at the level of Ste12p transcription factor (Zhu et al., 2000; 
Burchett et al., 2001). Although Aar2p was found to be an in vitro substrate for Prr2p 
(Ptacek et al., 2005) that does not necessarily mean that Prr2p will phosphorylate 
Aar2p in vivo. Even if it does, it might not phosphorylate S253 and therefore will not 
play any role regulating Aar2p/Prp8p interaction, as my results suggest. Prr2p can 
possibly phosphorylate one or more of the other Aar2p phospho-sites described in 
this work and play a role regulating a hypothetical Aar2p interaction with another 
protein. 
Gcn2 - General Control Nonderepressible 2 (Lucchini et al., 1984) - is a kinase 
that in response to starvation phosphorylates the alpha-subunit of translation 
initiation factor eIF2 (Hinnebusch & Fink, 1983; Thireos et al., 1984; Hinnebusch & 
Natarajan, 2002) and is activated by uncharged tRNAs and the Gcn1p-Gcn20p 
 65 
complex (Garcia-Blanco et al., 2000; Kubota et al., 2001). Gcn2p also has a role in 
DNA damage checkpoint control (Menacho-Marquez et al., 2007). Aar2p was 
isolated in a complex with other proteins (Brr2p, Prp4p, Prp6p, Prp8p, Prp31p, 
Snu114p, Snu66p, Rpl27b, Ssa2, Tef2, Ura2 and Utp21), being identified as physical 
interactors of Gcn2p (Gavin et al., 2006). With the exception of Aar2p, all the 
splicing factors in this complex are components of the U4/U6.U5 tri-snRNP (Brr2p, 
Prp4p, Prp6p, Prp8p, Prp31p, Snu114p and Snu66p) and Brr2p, Prp8p and Snu114p 
are also found in the mature U5 snRNP. Adding this information to my results leads 
to the conclusion that Gcn2p does not phosphorylate Aar2p S253 and that Aar2p 
might not even be a Gcn2p substrate. The kinase may actually act on other tri-snRNP 
proteins isolated in the complex with Aar2p. 
Several questions were answered by the work described in this chapter and the 
data obtained raise others. These results lead me to question what will be the effect 
of introducing the Aar2p phosphomutations into the genome of a yeast strain and if 
there will be implications on Aar2p association with U5 snRNP. 
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CHAPTER 5 – Aar2p and the U5 snRNP 
 
5.1. Introduction 
The results presented so far in this thesis indicate that residue S253 in Aar2p 
may be a landmark for the Aar2p/Prp8p interaction (Chapter 4 - Section 4.4). The 
phosphorylation of this serine possibly regulates an important step for U5 snRNP 
maturation - the substitution of Aar2p by Brr2p on C-terminal Prp8p. 
To understand more about the involvement of Aar2p in U5 snRNP maturation, 
I inserted mutations at the five described phosphosites (Chapter 3 - Section 3.4) into 
the genome of a yeast strain. In this chapter I study their effect on cell growth and on 
Aar2p interaction with U5 snRNP components. 
I observe that the phosphomutations do not cause growth phenotypes when 
inserted into the genome of BY4742 cells but confer cold sensitivity at 14˚C when 
introduced into the genome of W303 cells. Also, contrary to what was expected, 
mutations S253A and S253E do not affect Aar2p interaction with endogenous Prp8p, 
or Aar2p association with U5 snRNA. 
 
5.2. Introducing phosphomutations into genomic AAR2 
In order to introduce the mutations into the genome, I transferred the 
C-terminal half of Aar2p bearing each mutation from the mutated pBTM116-1-Aar2 
plasmids into the pGID3 plasmid (Decourty et al., 2008). This plasmid allows 
inserting the mutations into genomic AAR2 together with a prMFα2NatR cassette 
(NAT selection), by PCR amplification and homologous recombination. A wt-NAT 
control was constructed alongside the phosphomutants. Because the promoter of the 
prMFα2NatR cassette is only active in MATα cells, BY4742α and W303α were used 
as recipient strains in these experiments. 
The mutations were first inserted into the genome of yeast strain BY4742 
without any visible growth defect at the temperatures tested (Figure 5.1). 
Subsequently the phosphomutations were introduced into the W303 strain and an 
interesting result was observed. W303 is cold sensitive at 14˚C, however the simple 
introduction of the prMFα2NatR-AAR2 cassette without any mutation - W303-NAT - 
rescues the cold-sensitive phenotype at 14˚C (Figure 5.2). The same effect was 
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observed with most of the phosphomutations except S253A, T274E and S331A. 
Cells in which the latter mutations were introduced behave like wt W303 cells, 
showing cold sensitivity at 14˚C (Figure 5.2). These results are somewhat surprising 
since it was expected that at least the S253E mutation would cause a relative growth 





Figure 5.1. Aar2p phosphomutations do not confer a growth phenotype when inserted 
into the genome of BY4742. Phosphomutant strains were plated on YPDA alongside 
BY4742 and BY4742-NAT controls and grown at 14, 18, 25, 33 and 36˚C. No growth 
phenotypes were detected with the introduction of the phosphomutations into the genome, all 




Figure 5.2. S253A, T274E and S331A confer cold-sensitivity when inserted into the 
genome of W303. Phosphomutant strains were plated on YPDA alongside W303 and 
W303-NAT controls and grown at 14, 18, 25, 33 and 36˚C. Some growth defects were 
observed at 14˚C. As can be seen by the W303-NAT growing at 14˚C, the prMFα2NatR 
cassette insertion into the genome rescues the W303 cold sensitivity by itself. This effect is 
detected in almost all the phosphomutants with the exception of W303-S253A-NAT, 
W303-T274E-NAT and W303-S331A-NAT, which reveal themselves as cold sensitive 
similarly to the W303 strain. 
 
 
5.3. The effect of phosphomutants on U5 snRNP association  
Despite the lack of significant phenotypes with the growth experiments, I 
studied the effect of mutations S253A/E on Aar2p association with U5 snRNP 
components, specifically Prp8p and U5 snRNA. 
I started looking at the level of Prp8p pulled-down by immunoprecipitated 
Aar2p in the strains W303, W303-NAT, W303-S253A-NAT, and 
W303-S253E-NAT (Figure 5.3). The Prp8p Western blot was quantified using the 
LI-COR Odyssey system and the ratios pulldown/input and pulldown/non-bound 
were calculated for all the strains (Figure 5.3, table). Contrary to what was observed 
with the Y2H S253A/E strains (Chapter 4, Figures 4.6 and 4.7), here the 
Aar2p-S253E mutant pulls down Prp8p at the same level as does the wt Aar2p 
(Figure 5.3, table). The prMFα2NatR cassette insertion appears to cause a reduction 
in the amount of Prp8p pulled down by Aar2p, when comparing the W303-NAT and 
W303 strains. Nonetheless, comparison of W303-S253A-NAT and 
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W303-S253E-NAT with their counterpart W303-NAT control does not indicate any 







Figure 5.3. Mutation S253E does not disrupt Aar2p/Prp8p interaction in vivo. Aar2p 
was immunoprecipitated from W303, W303-NAT, W303-S253A-NAT, and 
W303-S253E-NAT cell extracts. The Western blot was probed with αPrp8p primary 
antibody and fluorescent α rabbit secondary antibody for quantification with the LI-COR 
Odyssey system. The table shows the fluorescence intensity recorded for each lane as well as 
the ratios pulldown/input and pulldown/non-bound. There is an apparent reduction of 
pulldown/input and pulldown/non-bound ratios on the W303-NAT in contrast to W303. In 
spite of this no significant difference is detected in the ratios of W303-S253A-NAT, and 
W303-S253E-NAT comparatively to the W303-NAT control. 
 
 
The next logical experiment was to determine the amount of U5 snRNA 
precipitated by the Aar2p-S253A and Aar2p-S253E mutant proteins. Consequently, 
Aar2p was immunoprecipitated and the level of pulled down U5 snRNA detected by 
Northern blot was quantified with the PhosphorImager (Figure 5.4). It is evident 
from the ratio pulldown/input that the level of precipitated U5 snRNA (both U5L and 
U5S forms) is the same in the four strains tested. These observations together with 
the results from the previous experiment indicate that Aar2p, Aar2p-S253A and 
Aar2p-S253E associate with the U5 snRNP at the same extent. 
strain input pulldown non-bound pulldown/input
W303 7.81 2.04 6.38 0.26
W303-NAT 9.27 1.13 6.89 0.12
W303-S253A-NAT 6.12 0.98 5.26 0.16
W303-S253E-NAT 5.51 0.7 5.85 0.13
0.19
0.12








Figure 5.4. Mutation S253E does not affect Aar2p association with U5 snRNA in vivo. 
Aar2p was immunoprecipitated as in the previous experiment and RNA was extracted from 
input samples and pulldowns. A Northern blot was performed with a U5 snRNA probe and 
the results quantified in the PhosphorImager are shown in the table. There is no difference in 
the ratio pulldown/input amongst the strains for either U5L or U5S, indicating that the 

























The results obtained in this chapter are highly discordant from those found in 
Chapter 4, perhaps raising the doubt if S253 has a role in Aar2p/Prp8p interaction 
regulation in vivo or not. It was expected that at least S253E would cause a growth 
phenotype since it severely disrupted Aar2p/Prp8p interaction in the Y2H system 
(Chapter 4, Figures 4.6 and 4.7). However, S253E neither caused a growth 
phenotype (Figure 5.2), nor did it disturb Aar2p interaction with Prp8p in vivo 
(Figure 5.3) or its association with U5 snRNA (Figure 5.4). 
The combination of several factors can contribute to the discrepancy between 
Chapter 4 and Chapter 5 results. One of them is the strategy used to insert the 
mutations into the genome. A prMFα2NatR cassette (Decourty et al., 2008) was 
inserted immediately after the AAR2 STOP codon by homologous recombination in 
order to replace the last 380bp of genomic AAR2 ORF with the same DNA sequence 
containing the desired phosphomutation. According to a tiling array analysis by 
Granovskaia (Granovskaia et al., 2010), AAR2 and SSA3 (the gene located 
immediately 3’ of AAR2) appear to be a single transcription unit. In this case, the 
prMFα2NatR cassette insertion may be disrupting SSA3 expression which could 
mask any effect caused by the phosphomutations. Ssa3p is part of the heat shock 
protein 70 family, being implicated in protein folding and response to stress 
(Werner-Washburne et al., 1987). This protein is an ATPase localized to the 
cytoplasm (Hartl & Hayer-Hartl, 2002) and has a function in SRP-dependent 
cotranslational protein-membrane targeting and translocation (Becker et al., 1996). 
On the other hand SSA3 gene deletion is viable with no visible phenotype (Giaever et 
al., 2002, Breslow et al., 2008) and this gene is induced at high temperatures or after 
diauxic shift (Werner-Washburne et al., 1987, Werner-Washburne et al., 1989) thus 
it is unlikely that it would interfere with Aar2p phosphomutant phenotypes, or that at 
least it would have a strong effect by itself. 
Another distressing factor seems to be the prMFα2NatR cassette itself. It was 
observed in this chapter that the simple prMFα2NatR cassette insertion alters W303 
normal cell growth (Figure 5.2). Also, it seems to reduce Aar2p interaction with 
Prp8p (Figure 5.3, note in the table that the ratios pulldown/input and 
pulldown/non-bound are reduced from W303 to W303-NAT strains), which can 
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mask the effect that S253E mutation would have in this interaction. 
Finally, the fact that Y2H strains are MATa while the strains in which the 
mutations were inserted into the genome are MATα can be another reason for 
concern. Aar2p was originally described as being required for splicing of MATa1 (a 
gene only expressed in MATa cells) but not of ACT1 (Nakazawa et al, 1991). The 
same authors did not detect AAR2 transcript in the logarithmic growth phase. They 
suggested that its expression level would be very low in the absence of appropriate 
mating pheromone induction, since they found one copy of pheromone-responsive 
element 5' of AAR2. Consequently we could be facing a mating-type specific effect 
with the S253E mutation. 
In order to reduce the problems described above and to be able to reach a 
definite conclusion regarding the role of Aar2p phosphosites in U5 snRNP 
maturation, the mutant strains will have to be constructed by plasmid shuffle. 
Probably the best strategy will be to start from a heterozygous diploid AAR2 deletion 
strain from the EUROSCARF deletion collection (BY4743; Mat a/α; his3Δ1/his3Δ; 
leu2Δ0/leu2Δ0; lys2Δ0/LYS2; MET15/met15Δ0; ura3Δ0/ura3Δ0; 
YBL074c::kanMX4/YBL074c). Thus two plasmid shuffle strains can be constructed 
in parallel, one MATa and another MATα, with plasmids containing AAR2 
endogenous promoter followed by AAR2 and SSA3 coding regions. This will clarify 
if the effects previously observed are mating type dependant or not, minimize 




CHAPTER 6 – Looking for Aar2p interactors: Y2H screens 
 
6.1. Introduction 
Besides Aar2p requirement for MATa1 splicing (Nakazawa et al., 1991), and 
its interaction with the U5 snRNP (Gottschalk et al., 2001; Boon et al., 2007), not 
much is known about this protein. To learn more about Aar2p, I planned a Y2H 
screen looking for new Aar2p interactors. 
As I have previously shown in Chapter 4, the full-length Aar2p has auto-
activation activity, which makes it ineffective for a Y2H screen. Hence, here I use 
the two Aar2p halves (already used for the Y2H assays in Chapter 4), Aar2p1-170 and 
Aar2p150-355 as baits for two separate Y2H screens. For each of these screens a 
genomic S. cerevisiae prey library is used (kindly provided by J. C. Rain, 
Hybrigenics, Paris). The resulting prey interactions are classified as A1, A2, A3, A4 
and B, following Fromont-Racine et al. (1997; see Table 6.2). The out of frame 
clones are regarded as significant since they can be expressed by frameshifting 
(Fromont-Racine et al., 1997). 
Both screens indicate that Aar2p N-terminal half interacts with Aar2p 
C-terminal half. Although no splicing factors are found in the prey clones, candidate 
new Aar2p interactors are unveiled. These results suggest links between Aar2p and 
intracellular transport, chromosome biology and DNA-damage repair. 
 
6.2. Aar2p1-170-bait screen 
Table 6.1 summarizes the general information for this screen. All the preys 
obtained are alphabetically compiled in Table 6.2 together with the corresponding 
class of interaction (see Table 6.2 on page 81). From the total 108 preys, 23 are A1 
class interactors, three are A2, 43 are A4 and 39 are B class interactors. No A3 class 
interactions are found. 
The principal hit of this screen (A1 interaction with 10 different clones 
isolated) is Aar2p itself, mostly C-terminal Aar2p. From the information on Table 
6.2, Aar2p170-276 can be defined as a minimal region of interaction for the bait 
Aar2p1-170. Other Aar2p1-170-bait A1 class interactors include Arc1p, Cab1p, 
Ecm32p, Fir1p, Fms1p, Mon1p, Nis1p, Rad4p, Rad16p, Rcy1p, Sam4p, San1p, 
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Sap1p, Sdc25p, Sno3p, Sse1p, Swi1p, Tdp1p, Yta6p, Yta7p, YDR026C and 
YMR209C. 
As A2 class interactors I find Rpl25p, Tdh2p and Tim9p. 
Also noteworthy are the Aar2p1-170 B class interactions with ARS902, an 
autonomously replicating sequence; TEL15R, telomere on the right arm of 
chromosome XV; and TEL12R-YP2, the most centromere-proximal region of two 
telomeric Y' elements on the right arm of chromosome XII. Surprisingly I do not find 
any splicing factors in the prey list. 
 
Table 6.1 – General information for Aar2p1-170 screen. 
Total number of interactions 1.7x108 
Mating efficiency 50.40% 
Total number of prey colonies 248 




6.3. Aar2p150-355-bait screen 
As shown in Table 6.3, from the 2.5x108 total interactions tested I only recover 
34 prey colonies. Table 6.4 lists in alphabetical order the four different prey proteins 
identified and their class of interaction with the Aar2p150-355-bait (see Table 6.4 on 
page 92). Two preys are A1 class interactors and the other two are A4. No A2, A3 or 
B class interactions are observed. 
The N-terminal half of Aar2p is the prime hit for this screen (13 different 
clones are obtained, A1 class interaction), Aar2p1-127 being defined as the minimal 
region of interaction for the Aar2p150-355-bait. All the Aar2p prey-clones start several 
base pairs into 5’ UTR of AAR2 and have several STOP codons before the initiation 
codon of the gene. 
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Rps8Ap is also an A1 interactor and Swi1p and YBL073W are A4 class 
interactors. Similarly to the Aar2p1-170 screen, I do not find any splicing factors 
amongst the prey clones. 
 
Table 6.3 – General information for Aar2p150-355 screen. 
Total number of interactions 2.5x108 
Mating efficiency 56.18% 
Total number of prey colonies 34 





6.4.1. Comparing Aar2p1-170-bait and Aar2p150-355-bait screens 
There is a large discrepancy regarding the amount of prey clones obtained in 
the two screens I preformed. The Aar2p1-170-bait screen produced a total of 108 
different preys and the Aar2p150-355-bait screen generated four preys only. We can 
speculate that Aar2p150-355 is not a prime contact region and it possibly regulates 
Aar2p interaction with other proteins. Since Aar2p150-355 encloses the five 
phosphosites, Aar2p conformational state could be changed via phospho- and 
dephosphorylation events making it more or less accessible to interact with other 
proteins. 
Rather exciting is that the most frequent hit for both screens is the 
complementary half of Aar2p (Aar2p170-276 and Aar2p1-127 are the minimal regions of 
interaction for Aar2p1-170 and Aar2p150-355 baits, respectively). This is a strong 
indicator that the two Aar2p halves interact with each other and suggests that Aar2p 
is a protein with a closed conformation. My results are in perfect agreement with 
very recent findings from the Wahl lab (Markus Wahl, Berlin – personal 
communication). This lab was able to crystallize Aar2p and observed that it is indeed 
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formed by two distinct domains very tightly associated with each other. 
A common prey for both screens is Swi1p. In the Aar2p1-170-bait screen it is an 
A1 class interactor and in the Aar2p150-355 it is an A4. Swi1p is a component of the 
SWI/SNF chromatin remodeling complex (Peterson et al., 1994; Smith et al., 2003) 
that controls transcription of several genes by remodeling chromosomes (Peterson & 
Herskowitz, 1992). 
Peculiarly, I do not find any splicing factor as prey in either of the two screens. 
Not even Prp8p that I showed to interact with Aar2p in Chapter 4 of this thesis. One 
possibility is that this interaction is not observed here because full-length Aar2p is 
required for interaction with Prp8p. Substantiating this hypothesis Wahl has recently 
crystallized Aar2p associated with the Prp8-RNaseH domain and observed Prp8p 
contact sites on both N- and C-terminal Aar2p (Wahl, 2010 – personal 
communication). 
The high number of different prey proteins found in the Aar2p1-170-bait screen 
suggests that this half is highly interactive with other proteins, or alternatively but 
less likely, that it is a sticky fragment. Despite that, I observe significant interactions 
with proteins from several categories: ubiquitin-binding proteins, chaperones, 
membrane and vacuolar proteins, a nuclear pore complex component, proteins 
localized to sites of polarized growth, chromatin-binding/remodeling proteins, a 
telomere binding protein, a DNA helicase and proteins involved in DNA-damage 
repair. Amongst the prey list there are also telomeric regions of three chromosomes. 
 
6.4.2. Aar2p and trafficking 
Recent Aar2p structural results reveal that it is composed of an N-terminal 
domain with a structure related to pore-forming toxins, and a C-terminal domain 
extremely similar to a VHS domain (Wahl, 2010, personal communication). The 
VHS domains are characteristic of proteins involved in clathrin-mediated 
endocytosis and vesicular trafficking (Lohi & Lehto, 1998). Also, these domains are 
thought to have a membrane-targeting/cargo recognition role and very frequently 
contain one or two ubiquitin-interacting motifs (reviewed in Lohi et al., 2002). 
Remarkably, I find as preys for Aar2p1-170-bait two ubiquitin-binding proteins, 
Cue2p and San1p. Cue2p has unknown function but contains two CUE ubiquitin-
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binding domains that might assist intramolecular mono-ubiquitination and coupling 
to ER degradation (Biederer et al., 1997; Shih et al., 2003). San1p is an Ubiquitin-
protein ligase, implicated in the degradation of abnormal nuclear proteins by the 
proteasome (Dasgupta et al., 2004; Gardner et al., 2005). Also in conformity I find 
Aar2p1-170-bait interacting with membrane and vacuolar proteins: Mon1p is required 
for fusion of autophagosomes and cvt-vesicles with the vacuole (Meiling-Wesse et 
al., 2002); and Kin1p is a serine/threonine kinase localized in the plasma membrane, 
which contributes to exocytosis regulation (Elbert et al., 2005). In accordance as well 
are the interactions of Aar2p1-170-bait with proteins directed to sites of polarized 
growth: Nis1p is localized at the bud neck where it interacts with septins (Iwase & 
Toh-e, 2001); Pkc1p is a serine/threonine kinase located in the mother-daughter bud 
neck and other sites of polarized growth and is fundamental for cell wall remodeling 
during growth (Levin et al., 1994; Watanabe et al., 1994; Andrews & Stark, 2000); 
Rcy1 is an F-box protein implicated in recycling plasma membrane proteins 
internalized by endocytosis (Wiederkehr et al., 2000; Galan, et al., 2001); YFR016C 
is a protein with unknown function; and finally Yta6p is a presumed ATPase of the 
CDC48/PAS1/SEC18 (AAA) family, localized only to the cortex of mother cells 
(Schnall et al., 1994; Swaffield & Purugganan, 1997; Beach & Bloom, 2001). 
Another interesting prey obtained with the Aar2p1-170-bait is Nup116p. This 
protein is a nuclear pore complex component and is located to both sides of the pore. 
It contains a GLFG motif that interacts with Mex67p (mRNA export factor) and with 
the karyopherin Kap95p (Rout et al., 2000; Strawn et al., 2001; Lutzmann et al., 
2005). Additionally, it was shown by Boon (2005) that Kap95p is required for 
nuclear import of Snu114p, U2, U5 and U6 snRNAs. Since Wahl observes Prp8p 
RNaseH β-hairpin binding in the groove between the two VHS helices, he suggests 
that Aar2p imports Prp8p into the nucleus via the same cargo-recognition tactic as 
other VHS domain proteins (Wahl, 2010 - personal communication). 
In conclusion, the evidence presented above suggests that Aar2p can be a 
transport factor for U5 snRNP-components, such as Prp8p; especially that it can be 




6.4.3. Aar2p and the chromosomes 
Other interesting preys interacting with the Aar2p1-170-bait are 
chromatin-binding proteins. I have: Swi1p (described above); Rlf2p is part of the 
major subunit of Chromatin Assembly Complex 1 (CAF-1) assembling histones on 
recently replicated DNA (Glowczewski et al., 2004) and involved in the maintenance 
of silent chromatin (Adams & Kamakaka, 1999); and Yta7p, which regulates histone 
gene expression after binding to chromatin (Gradolatto et al., 2008; Fillingham et al., 
2009). 
Furthermore, I find Aar2p1-170-bait associating with a potential 
telomere-binding Arc1p protein (Frantz & Gilbert, 1995) and to three telomeric 
regions. ARS902 is one of them; it is a presumed replication origin (ARS) on 
chromosome IX telomere (Wyrick et al., 2001; Raveendranathan et al., 2006; Xu et 
al., 2006). ARSs are believed to facilitate DNA unwinding, thereby enhancing the 
replication initiation efficiency (Shirahige et al., 1993). In agreement, an A1 class 
Aar2p1-170 interactor is Ecm32p, a DNA-dependent ATPase/DNA helicase part of the 
Dna2p- and Nam7p-like family of helicases (Biswas et al., 1995; Bean & Matson, 
1997). The other two telomeric regions on the prey list are TEL12R-YP2 and 
TEL15R. TEL12R-YP2 is the most centromere-proximal of two telomeric Y' 
elements on the right arm of chromosome XII and includes an ARS consensus 
sequence (Louis & Haber, 1992; Pryde et al., 1997; Yamada et al., 1998). TEL15R is 
the chromosome XV right arm telomere with typical telomeric structure enclosing an 
X element core sequence, X element combinatorial repeats, a long Y' element, and a 
very short terminal stretch of telomeric repeats (Louis et al., 1994; Louis, 1995). 
Interestingly and in complement of these results, when searching for genes that affect 
telomere length using a collection of strains that carry hypomorphic alleles (DAmP 
collection) Ungar and colleagues observed that AAR2-DAmP induces telomeres 
longer than those found in wt (Ungar et al., 2009). 
Integrating all this information I suggest that Aar2p can have an effect in 





6.4.4. Aar2p and DNA-damage repair 
The Aar2p1-170-bait captured numerous preys involved in DNA damage repair, 
many of them related to UV-induced DNA damage. They are Dna2p, Mus81p, 
Ogg1p, Rad4p, Rad16p, Rad53p, Rad54p and Tdp1p. I will discuss each of these 
preys in more detail. 
Dna2p is a DNA replication factor with single-stranded DNA-dependent 
ATPase, ATP-dependent nuclease, and helicase activities (Bae et al., 1998) and is 
also involved in Okazaki fragment processing (Bae & Seo, 2000). 
Mus81p is an Mms4p-Mus81p endonuclease subunit that cleaves branched 
DNA (Bastin-Shanower et al., 2003); it is implicated in replication fork stability 
during meiotic recombination (Oh et al., 2008) and has a role in the response to UV 
and methylation-induced DNA damage (Interthal & Heyer, 2000). 
Ogg1p, acts on mitochondrial DNA oxidative damage repair (Nash et al., 
1996; Singh et al., 2001) and mediates UVA resistance (Kozmin et al., 2005). 
Rad4p is a homolog of human XPC protein (Foury, 1997), it is a subunit of 
Nuclear Excision Repair Factor 2 (NEF2) (de Laat et al. 1999; Prakash & Prakash, 
2000) and together with Rad23p recognizes and binds UV damaged DNA. Rad4p is 
ubiquitinated and degraded by the 26S proteasome, in a process controlled by 
Rad23p (Lommel et al. 2002; Gillette et al., 2006). 
Rad16p together with Rad7p form Nucleotide Excision Repair Factor 4 
(NEF4) complex (Gillette et al., 2006). NEF 2 and NEF4 bind synergistically to UV 
damaged DNA in an ATP-dependent manner during nucleotide excision repair 
(Guzder, et al. 1999; Prakash & Prakash, 2000). 
Rad53p is a kinase that in reaction to DNA damage induces cell-cycle arrest. It 
associates with hyperphosphorylated Rad9p and is activated in trans (Schwartz et al., 
2002; Toh & Lowndes, 2003). Rad53p interacts as well with ARS1 (autonomously 
replicating sequence) and causes initiation of DNA replication (Dohrmann & 
Sclafani, 2006). 
Rad54p is a member of the SWI/SNF family (Eisen et al., 1995). Throughout 
vegetative growth and meiosis this protein is implicated in DNA double-strand 
breaks repair. Rad54p is a DNA-dependent ATPase that alters the topology of 
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double-stranded DNA and promotes strand exchange (Clever et al., 1997; Petukhova 
et al., 1999). 
Finishing this long list of DNA damage related preys there is Tdp1p. This 
protein repairs DNA lesions caused by topoisomerases I and II (Pouliot et al., 1999; 
Nitiss et al., 2006; He et al., 2007). 
The report of Aar2p S331 being phosphorylated after DNA-damage induction 
by genotoxic stress (Albuquerque et al., 2008) is in agreement with the results above 
and suggests a function for Aar2p in DNA-damage repair. In addition, Ben-Aroya et 
al. (2010) reported a strong chromosome instability phenotype caused by a random ts 
AAR2 mutant in a study that proves a link between proteasome degradation and 
double strand break (DSB) repair. The authors demonstrate for the first time a DSB 
repair protein (Mms22p) being ubiquitinated and targeted to the proteasome 
(Ben-Aroya et al., 2010). It is then possible that after DNA damage induction (UV in 
particular) S331 is phosphorylated, targeting Aar2p to sites of double strand breaks. 
There, via its VHS domain Aar2p would recognize ubiquitinated DSB proteins, bind 
them and escort them to the proteasome for degradation. 
 
6.4.5. Conclusion 
The results I present in this chapter support three potential new functions for 
Aar2p. One of them, the U5 snRNP-components transport, corroborates the proposed 
model for U5 snRNP maturation (Boon et al., 2007), adding a new role for Aar2p in 
it. The other two, the putative roles for Aar2p in chromatin remodeling and DNA 
damage repair, corroborate and complement previous and recent unpublished 
findings (e.g. Albuquerque et al., 2008, Ben-Aroya et al., 2010, Wahl, 2010 - 
personal communication). Altogether, these results open new perspectives for the 
study of this interesting protein. 
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Table 6.2 –Results from the Y2H screen preformed with Aar2p1-170 as bait. Prey interactions were classified as A1, A2, A3, A4 and B, according to 
Fromont-Racine et al., 1997. A1 are the most significant interactions in which more than one overlapping fusion is found. A2, A3 and A4 are only found as a 
single fusion, even if the same fusion is found several times. A2 are fusions starting close to the initiation codon of an ORF. A3 are fusions containing 
coding inserts of more than 1000 bases. A4 are all the other fusion types. B fusions are non-biological peptides, like antisense or intergenic regions. No A3 
class interactions are found in this screen. 
 







AAR2 A1 894 ChrII 87282-86389 170-355 (end) 1 In frame 
    954 ChrII 87678-86725 37-355 1 In frame 
    894 ChrII 87538-86645  84-355 1 Out of frame -1 
    511 Chr II 87439-86929 117-286 1 In frame 
    495 Chr II 87453-86959 113-276 1 In frame 
    860 Chr II 87678-86819 39-313 1 In frame 
    495 Chr II 87453-86959 113-276 2 Out of frame +1 
    993 Chr II 87679-86687 39-355 1 Out of frame +1 
    889 Chr II 87666-86778 42-330 2 Out of frame +1 
    561 Chr II 87660-87099 94-279 1 Out of frame -1 
ACS1 A4 969 Chr I 44895-43927 44-365 1 In frame 
APA1 A4 897 Chr III 38106-37210 232-321 (end) 1 Out of frame +1 
ARC1 A1 702 Chr VII 307831-308532 132-362 1 In frame 
    720 Chr VII 307739-308458 103-339 1 Out of frame -1 
    639 Chr VII 307833-308471 133-344 1 In frame 81 
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ARO1 A4 520 Chr IV 708553-709072 1358-1530 1 In frame 
ATG26 A4 507 Chr XII 532464-531958 645-810 1 Out of frame -1 
CAB1 A1 354 Chr IV 1498265-1498618 14-131 2 In frame 
    388 Chr IV 1498265-1498652 15-141 1 Out of frame -1 
CUE2 A4 378 Chr XI 272419-272796 300-425 1 In frame 
DNA2 A4 493 Chr VII 425793-425301 1130-1293 1 In frame 
DYN1  A4 153 Chr XI 541032-540880 2181-2228 2 In frame 
ECM1 A4 918 Chr III 45911-44994 333-637 2 Out of frame -1 
ECM32 A1 510 Chr V 543970-544480 763-932 1 Out of frame +1 
    553 Chr V 543943-544495 754-937 1 Out of frame -1 
ERR2 A4 370 Chr XVI 10397-10766 36-143 1 In frame 
FAS2 A4 546 Chr XVI 110428-110974 593-774 2 In frame 
FIR1 A1 858 Chr V 216810-217668 584-876 (end) 1 Out of frame +1 
    836 Chr V 216815-217650 589-876 1 In frame 
    436 Chr V 217207-217642 716-859 1 In frame 
    869 Chr V 216815-217683 586-868 1 In frame 
FMS1 A1 336 Chr XIII 316332-316667 320-430 2 In frame 
    337 Chr XIII 316332-316667 320-430 1 Out of frame +1 
HAL5 A4 893 Chr X 108943-108051 172-469 2 In frame 82 
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KIN1 A4 362 Chr IV 694796-695157 36-151 2 In frame 
MHP1 A4 892 Chr X 362243-363134 336-630 1 In frame 
MLS1 A4 864 Chr XIV 406366-407211 3-290 1 In frame 
MON1 A1 589 Chr VII 276706-276118 12-195 1 In frame 
    567 Chr VII 276701-276135 8-195 2 In frame 
MSA1 A4 743 Chr XV 449802-450544 127-369 1 Out of frame -1 
MUS81 A4 764 Chr IV 1247626-1248389 518-632 (end) 1 Out of frame -1 
NAR1 A4 784 Chr XIV 199099-198316 313-491 1 Out of frame +1 
NIS1 A1 489 Chr XIV 480527-481015 255-407 (end) 1 Out of frame +1 
    890 Chr XIV 480776-481665 337-407 1 Out of frame +1 
NMA111 A4 675 Chr XIV 397326-398000 882-997 1 Out of frame -1 
NUP116 A4 884 Chr XIII 365517-364634 337-687 1 In frame 
OGG1 A4 328 Chr XIII 152346-152673 160-252 5 In frame 
PIM1 A4 491 Chr II 181017-180527 89-250 1 In frame 
PKC1 A4 901 Chr II 16736-15836 321-621 1 In frame 
PPE1 A4 440 Chr VIII 249579-249140 23-168 1 In frame 
RAD4 A1 200 Chr V 502055-501856 279-344 1 In frame 
    201 Chr V 502056-501856 279-344 1 Out of frame +1 




    741 Chr II 467338-468078 33-279 1 Out of frame -1 
    574 Chr II 467404-467977 57-296 1 Out of frame -1 
RAD53 A4 832 Chr XVI 262916-262085 428-692 1 In frame 
RAD54 A4 523 Chr VII 194651-194129 539-760 2 In frame 
RCY1 A1 476 Chr X 51151-50676 668-825 1 In frame 
    393 Chr X 51068-50676 696-825 1 Out of frame -1 
    446 Chr X 51115-50670 680-825 1 Out of frame +1 
RLF2 A4 494 Chr XVI 595084-595577 87-385 1 Out of frame -1 
RPL25 A2 899 Chr XV 79965-80863 1-171 1 
In frame, but there 
are 4 STOP codons 
before RPL25 ATG 
RPO31 A4 290 ChrXV 541860-541571 763-858 1 In frame 
SAM4 A1 667 Chr XVI 25503-26170 140-325 (end) 1 In frame 
    776 Chr XVI 25431-26206 116-325 1 Out of frame +1 
      Chr XVI 25545-26078 154-325 1 Out of frame +1 
SAN1 A1 542 Chr IV 743872-743331 2-181 1 In frame 
    410 Chr IV 743804-743395 24-159 1 Out of frame +1 
SAP1 A1 890 Chr V 245066-244177 481-757 1 Out of frame -1 
    735 Chr V 245104-244370 468-724 1 Out of frame -1 
SDC25 A1 751 Chr XII 115531-116281 879-1048 (end) 1 In frame 
    755 Chr XII 115527-116281 896-1048 1 Out of frame -1 84 
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SNO3 A1 902 Chr VI 11053-10152 1-223 1 In frame 
    912 Chr VI 11053-10141 1-333 (end) 1 In frame 
SPT8 A4 469 Chr XII 251771-251303 438-593 1 Out of frame +1 
SSE1 A1 199 Chr XVI 351916-351718 120-185 1 In frame 
    412 Chr XVI 352126-351718 50-185 1 Out of frame -1 
STP4 A4 840 Chr IV 367744-366905 158-434 1 In frame 
SWI1 A1 575 Chr XVI 522645-523249 546-746 1 In frame 
    611 Chr XVI 522639-523249 546-746 1 In frame 
    745 Chr XVI 521283-522027 92-339 1 Out of frame -1 
TDH1 A4 545 Chr X 338267-338811 65-182 1 Out of frame +1 
TDH2 A2 567 Chr X 454693-454127 1-182 5 In frame 
TDP1 A1 950 Chr II 670193-669244 35-355 1 In frame 
    967 Chr II 670239-669743 19-183 1 Out of frame -1 
TED1 A4 360 Chr IX 279402-279761 327-443 1 In frame 
THI21 A4 814 Chr XVI 54715-53902 148-415 1 In frame 
TIM9 A2 519 ChrV 116970-117488 1-88 (end) 1 In frame 
TRA1 A4 836 Chr VIII 308978-309813 2073-2349 1 Out of frame +1 




VID27 A4 283 Chr XIV 247974-248256 173-262 2 In frame 
VTC2 A4 514 Chr VI 133143-133656 440-617 1 In frame 
YOR1 A4 526 Chr VII 1054327-1054852 500-672 1 In frame 
YTA6 A1 439 Chr XVI 416974-417412 406-533 6 In frame 
    438 Chr XVI 416975-417412 406-533 1 In frame 
YTA7 A1 872 Chr VII 1031280-1032152 
1303-1379 
(end) 1 Out of frame -1 
    838 Chr VII 1031293-1032131 1315-1379 1 In frame 
    910 Chr VII 1031280-1032190 1303-1379 2 Out of frame -1 
YAL037W A4 241 Chr I 74040-74280 8-87 1 In frame 
YCL074W A4 150 Chr III 3369-3519 206-227 1 In frame 
YCR013C A4 176 Chr III 138680-138505 124-181 1 In frame 
YCR015C A4 814 Chr III 141823-141010 118-317 (end) 1 In frame 
YDR026C A1 422 Chr IV 493251-492829 340-475 2 Out of frame +1 
    834 Chr IV 493243-492409 342-570 (end) 1 Out of frame -1 
    855 Chr IV 493243-492388 342-570 1 Out of frame -1 
YFR016C A4 828 Chr VI 177863-177034 958-1234 (end) 1 Out of frame -1 
YGL109W A4 723 Chr VII 303678-304400 55-107 (end) 1 Out of frame +1 
YMR209C A1 873 Chr XIII 686693-685821 197-457 (end) 2 In frame 86 
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    874 Chr XIII 686693-685820 197-457 2 In frame 
    895 Chr XIII 686698-685804 198-457 1 Out of frame +1 
    772 Chr XIII 686693-685922 198-457 1 In frame 
TEL12R-YP2 B 327 Chr XII 1071337-1071663 - 1 Y' element 
TEL15R B 325 Chr XV 1090965-1091289 - 1 Telomere 
    320 Chr XV 1090965-1091284 - 2   
ARS902 B 466 Chr IX 8399-8864 - 1 Autonomously replicating sequence 
RDN5-1 B 170 Chr XII 459631-459800 - 1 rRNA 
RDN18-1 B 108 Chr XII 456915-457022 - 1 rRNA 
RDN18-2 B 108 Chr XII 466052-466159 - 1 rRNA 
5’ UTR YIR014W B 245 Chr IX 380854-381099 - 1   
Antisense AAC3 B 647 ChrII 416982-416336 - 1 - 
Antisense BAT2 B 504 Chr X 705811-705308 - 2 - 
    741 Chr X 705806-705066 - 1 - 
    542 Chr X 705812-705271 - 1 - 
Antisense BAT2-
HMS2 B 850 Chr X 705806-704957 - 2 
Antisense sequence 
that spans from C-
terminal HMS2 to N-
terminal BAT2 
    623 Chr X 705806-705184 - 2   87 
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    854 Chr X 705812-704959 - 1   
    805 Chr X 705806-705002 - 1   
    833 Chr X 705806-704974 - 1   
    735 Chr X 705812-705078 - 1   
    741 Chr X 705806-705066 - 1   
    705 Chr X 705812-705108 - 1   
    695 Chr X 705812-705118 - 1   
    641 Chr X 705812-705172 - 1   
    653 Chr X 705812-705160 - 1   
    806 Chr X 705806-705001 - 1   
    725 Chr X 705812-705088 - 1   
    714 Chr X 705812-705099 - 1   
Antisense CDC60 B 271 Chr XVI 248808-248538 - 1   
Antisense DAP2 B 706 Chr VIII 166097-166802 - 1 Antisense sequence that spans DAP2 
    424 Chr VIII 166112-166535 - 1   
Antisense EAF3 B 655 Chr XVI 609573-610227 - 1 
Antisense sequence 
that spans from N-
terminal EAF2 
Antisense EMI2 B 870 Chr IV 1475612-1476481 - 1 
Antisense sequence 
that spans N-terminal 
half EMI2 
Antisense GAL4 B 101 Chr XVI 79714-79814 - 2   88 
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    102 Chr XVI 79714-79815 - 3   
Antisense HAP1 B 612 Chr XII 648171-647486 - 1   
    612 Chr XII 648164-647553 - 1   
    672 Chr XII 648178-647507 - 1   
Antisense HEK2 B 754 Chr II 161656-160903 - 1   
    728 Chr II 161656-160928 - 1   
    684 Chr II 161656-160973 - 1   
      ChrII 161656-160973 - 1   
Antisense HIR3 B 896 Chr X 694161-695056 - 1   
Antisense IMD2 B 560 Chr VIII 554685-554126 - 1   
Antisense KIC1 B 189 Chr VIII 317199-3107011 - 1   
Antisense PAU1 B 466 Chr X 8382-8847 - 1   
Antisense PDR11 B 204 Chr IX 331316-331519 - 1   
    210 Chr IX 331316-331525 - 13   
    214 Chr IX 331316-331529 - 1   
    891 Chr IX 331315-332205 - 2   
    196 Chr IX 331330-331525 - 1   
    192 Chr IX 331316-331507 - 1   
    192 Chr IX 331336-331524 - 1   89 
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    189 Chr IX 331317-331525 - 1   
    846 Chr IX 331315-332160 - 1   
    364 Chr IX 331295-331658 - 1   
    702 Chr IX 331331-332032 - 4   
    920 Chr IX 331325-332245 - 1   
    917 Chr IX 331325-332241 - 1   
    200 Chr IX 331325-331524 - 1   
Antisense PDR12 B 96 Chr XVI 445796-445891 - 5   
Antisense PRP40 B 250 Chr XI 419509- 419260 - 1   
    308 Chr XI 419494-419187 - 2   
    782 Chr XI 419542-418761  - 1   
Antisense RDN18 B 108 Chr XIII 466052-466159 - 1   
Antisense RDN37-2 B 108 Chr XII 466052-466159 - 1   
Antisense RPL35B B 248 Chr IV 218336-218089 - 1   
Antisense RPL41B B 573 Chr IV 221256-221828 - 1   
Antisense SNF3 B 513 Chr IV 114077-113565 - 1   
Antisense SSN3 B 667 Chr XVI 472728-473394 - 1   
Antisense STP1 B 344 Chr IV 1387186-1386843 - 1   
Antisense STP1-
MRPL28 B 781 
Chr IV 1387192-





Antisense UTR2 B 461 Chr V 78368-78828 - 1   
    444 Chr V 78811-78368 - 1   
Antisense YDR026C B 856 Chr IV 492460-493315 - 1   
Antisense YVH1 B 477 Chr IX 405421-405897 - 2   
Intergenic region 1 B 142 Chr XIII 619582-619723 - 2   
Intergenic region 2 B 328 Chr XI 644081-644408 - 1   
Intergenic region 3 B 670 Chr IV 543886-544555 - 1   
Intergenic region 4 B 473 Chr IV 476408-475936 - 2   





Table 6.4 –Results from the Y2H screen preformed with Aar2p150-355 as bait. Prey interactions were classified as A1, A2, A3, A4 and B, according to 
Fromont-Racine et al., 1997. A1 are the most significant interactions in which more than one overlapping fusion is found. A2, A3 and A4 are only found as a 
single fusion, even if the same fusion is found several times. A2 are fusions starting close to the initiation codon of an ORF. A3 are fusions containing 
coding inserts of more than 1000 bases. A4 are all the other fusion types. B fusions are non-biological peptides, like antisense or intergenic regions. No A2, 
A3 nor B class interactions are found in this screen. 
 







AAR2* A1 817 Chr II 88094-87278 1-168 1 
Out of frame -1, but 
there are 4 STOP 
codons before AAR2 
ATG 
    824 Chr II 88094-87271 1-172 2 
Out of frame -1, but 
there are 4 STOP 
codons before AAR2 
ATG 
    800 Chr II 88088-87289 1-166 6 
Out of frame -1, but 
there are 4 STOP 
codons before AAR2 
ATG 
    809 Chr II 88094-87286 1-167 2 
Out of frame -1, but 
there are 4 STOP 
codons before AAR2 
ATG 
  
  865 Chr II 88169-87305 1-160 1 
Out of frame +1, but 
there are 4 STOP 





    812 Chr II 88094-87283 1-168 6 
In frame, but there 
are 7 STOP codons 
before wAAR2 ATG 
    812 Chr II 88094-87283 1-168 6 
In frame, but there 
are 7 STOP codons 
before AAR2 ATG 
    872 Chr II 88190-87319 1-156 1 
Out of frame -1, but 
there are 4 STOP 
codons before AAR2 
ATG 
    802 Chr II 88090-87289 1-166 1 
In frame, but there 
are 7 STOP codons 
before AAR2 ATG 
    797 Chr II 88088-87291 1-166 1 
Out of frame -1, but 
there are 4 STOP 
codons before AAR2 
ATG 
    810 Chr II 88094-87284 1-168 1 
Out of frame -1, but 
there are 4 STOP 
codons before AAR2 
ATG 
    745 Chr II 88169-87424 1-121 1 
Out of frame +1, but 
there are 4 STOP 
codons before AAR2 
ATG 
  
  940 Chr II 88109-87170 1-206 1 
Out of frame -1, but 
there are 4 STOP 




RPS8A A1 681 Chr II 88924-88244 67-end 1 Out of frame +1 
    792 Chr II 88924-88133 67-end 1 Out of frame +1 
    788 Chr II 88924-88137 67-end 1 Out of frame +1 
    847 Chr II 88924-88078 67-end 1 Out of frame +1 
    791 Chr II 88924-88134 67-end 1 Out of frame +1 
SWI1 A4 892 Chr XVI 522693-523584 562-858 1 In frame 






CHAPTER 7 - Final discussion and future work 
 
7.1 Aar2p in U5 snRNP biogenesis 
Aar2p was originally described as being essential for MATa1 pre-mRNA 
splicing, one of the few two-intron genes in budding yeast, but not required for ACT1 
splicing (Nakazawa et al., 1991). Later this protein was isolated together with U5 
snRNA and some components of the U5 snRNP. However it was never found as part 
of the U4/U6.U5 tri-snRNP and therefore is not considered to be an active participant 
in the splicing reaction (Gottschalk et al., 2001). Aar2p is necessary for splicing in 
vivo but not in vitro. Its depletion causes a reduction in the tri-snRNP levels and 
interferes with later rounds of splicing, indicating a possible role for Aar2p in snRNP 
recycling (Gottschalk et al., 2001). Aar2p was suggested to be involved in U5 
snRNP biogenesis (Gottschalk et al., 2001; Boon et al., 2007). The Aar2p-U5 snRNP 
complex is viewed as an intermediate particle in U5 snRNP biogenesis and is 
thought to assemble in the cytoplasm (Boon et al., 2007). Nevertheless, not much is 
known about Aar2p’s exact role and mechanism of action in either snRNP recycling 
or U5 snRNP biogenesis. 
I show in Chapter 3 of this study that Aar2p is phosphorylated in five 
aminoacid residues: S253, T274, Y328, S331 and T345; among them, S253 is very 
conserved between budding yeast and several higher eukaryotes. 
From the results presented in Chapter 4, S253 comes across as an important 
element in regulation of the Aar2p/Prp8p interaction, which is disrupted in vivo by 
the phosphomimetic mutant S253E. At the same time, I rule out the Prr2p and Gcn2p 
kinases in regulating the Aar2p/Prp8p interaction. Results from Chapters 4 and 5 
illustrate that this interaction is weak and only a small fraction of the total Prp8p is 
associated with Aar2p in vivo. Additionally I detect a low level of U5 snRNA 
associated with Aar2p, implying that the Aar2p-U5 snRNP precursor form is not 
very abundant in the cell. 
Lastly, in Chapter 6 I find new Aar2p interactors. These suggest novel roles for 
Aar2p in protein transport, chromosome biology and DNA damage repair. I also 
observe Aar2p N-terminal fragment interacting with the Aar2p C-terminal, which 
suggests that the protein has a closed conformation. 
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My data support and complement the U5 snRNP maturation model proposed 
by Boon et al. (2007). Immunoprecipitation results suggest that S253 
phosphorylation can be the mechanism for Aar2p replacement by Brr2p on 
C-terminus Prp8p, allowing U5 snRNP maturation to proceed. Aar2p can function 
then as a chaperone for the Brr2p/Prp8p interaction, preventing Brr2p from binding 
Prp8p before it is required and accelerating the splicing process inadvertently. My 
results corroborate also this model’s assumption that the Aar2p/Prp8p and 
Brr2p/Prp8p complexes are in equilibrium. I observe growth defects when this 
equilibrium is disrupted by a simultaneous overproduction of Aar2p and E3 or E3H 
Prp8p fragments in the cell. 
Regarding a potential role for Aar2p on Prp8p nuclear import Chapters 4 and 6 
show potentially discordant data. In Chapter 4, I discard a role for Aar2p in the 
nuclear import of both Prp8p and Snu114p on the basis of AAR2 overexpression and 
repression, under control of the GAL1 promoter. I observe the same localisation 
pattern for GFP-Prp8p and GFP-Snu114p in both conditions. It is suggested that 
Aar2p level in the cell is normally very low (Nakazawa et al., 1991). In addition, it is 
possible that the GAL1 promoter is leaky, allowing Aar2p expression to levels 
similar to the normal situation during growth in glucose. In this case Prp8p and 
Snu114p localisation will not be affected by AAR2 repression, since Aar2p level will 
be sufficient to maintain its function at normal levels. Most likely the Prp8p NLS has 
a major role in its nuclear import (Boon et al., 2007); Aar2p could be part of the 
process but with an accessory carrier function. If this is the case, the lack of 
alteration in Prp8p and Snu114p localisation with Aar2p overproduction and 
depletion is explained. 
In Chapter 6 I show Aar2p interacting in a Y2H assay with Nup116p, a nuclear 
pore protein that interacts with Kap95p (Rout et al., 2000; Strawn et al., 2001; 
Lutzmann et al., 2005). Boon (2005) showed that Kap95p is required for the nuclear 
import of Snu114p and U5 snRNA. The same author describes the Prp8p NLS as 
being responsible for Prp8p, Snu114p and U5 snRNA nuclear import but not 
interfering with Aar2p localisation (Boon et al., 2007). ΔNLS-Prp8p cells show 
defects on tri-snRNP formation and consequently on pre-mRNA splicing (Boon et 
al., 2007). However, splicing is not completely abolished and the cells survive, 
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suggesting that an additional mechanism for Prp8p import must be in place. Aar2p, 
which is normally localised in both nucleus and cytoplasm, accumulates in the 
nucleus after PRP8 overexpression. Upon Prp8p depletion Aar2p shows a normal 
localisation pattern, indicating that Aar2p localisation is somehow linked to Prp8p 
(Boon et al., 2007). Furthermore, based on his structural data Wahl suggests that 
Aar2p binds Prp8p and may mediate its nuclear import (M. Wahl, personal 
communication). In resume, the evidence points to a role for Aar2p in Prp8p 
transport. 
Aar2p C-terminal is found to interact with Prp8p and is composed of a VHS 
domain, typical of proteins involved in vesicular transport (M. Wahl, personal 
communication). VHS domains very frequently have associated ubiquitin interacting 
motifs (Lohi et al., 2002). This evidence agrees with Prp8p Jab1/MPN domain 
binding ubiquitin, and the isolation of Prp8p-ubiquitin with the tri-snRNP (Bellare et 
al., 2006, 2008). 
Disruption of ubiquitin recognition in splicing extracts in vitro causes the 
spliceosome to stall at complex B. This effect is caused by a reduction in the tri-
snRNP level due to an increase in the rate of U4/U6 unwinding catalysed by Brr2p. 
Therefore ubiquitin recognition seems to control tri-snRNP disassembly through 
Prp8p-ubiquitin repressing Brr2p unwinding activity (Bellare et al., 2008). The same 
authors do not rule out that ubiquitin recognition may also have a role promoting tri-
snRNP formation (Bellare et al., 2008) and U5 snRNP maturation directly affects tri-
snRNP formation. Additionally, in Chapter 6 I find two ubiquitin interacting proteins 
as Aar2p preys, reinforcing the idea that Aar2p recognizes and binds ubiquitinated 
proteins. This suggests that Aar2p can bind Prp8p-ubiquitin and facilitate its nuclear 
import. Thus, ubiquitination could be an additional mechanism regulating U5 snRNP 
maturation. 
Summarizing the data above, I introduce new elements to the U5 snRNP 
maturation model (Figure 7.1). Aar2p would recognize Prp8p-ubiquitin in the 
cytoplasm and bind it through its VHS cargo-recognition domain. The 
Aar2p/Prp8p/Snu114p/U5 snRNP precursor complex is then imported to the nucleus 
in a Kap95-dependent manner due to cooperation between the Prp8p NLS and 
Aar2p. Once in the nucleus, a kinase X would phosphorylate S253, disrupting the 
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Aar2p/Prp8p interaction. Brr2p can then bind C-terminal Prp8p and complete the U5 





Figure 7.1. Updated view of the U5 snRNP maturation model. New elements are added to the U5 
snRNP maturation model proposed by Boon et al. (2007). Special emphasis is given to Aar2p S253 
phosphorylation, which can be the trigger for disruption of the Aar2p/Prp8p interaction. Prp8p-
ubiquitin is also added to this model, as a possible mechanism for Aar2p recognition and binding to 
Prp8p in the cytoplasm. 
 
 
7.2 New roles for Aar2p 
From the Y2H screen results I present in Chapter 6, potential new roles for 
Aar2p can be suggested. In particular, roles in DNA damage repair and chromatin 
remodeling. 
Using Aar2p1-170 as bait for the Y2H screen I obtain a vast number of prey 
proteins. Amongst them I find ubiquitin-binding proteins, proteins involved in 
DNA-damage repair (a great part of them associated with UV-induced DNA 
damage) and one DNA helicase. In agreement, Aar2p S331 is phosphorylated upon 
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DNA damage (Albuquerque et al., 2008) reinforcing the hypothesis of a link 
between Aar2p and DNA damage repair. This suggests a functional separation of the 
Aar2p phosphosites. S253 would be involved in U5 snRNP biogenesis and S331 in 
DNA damage repair. Also here the Aar2p VHS domain could take part, mediating 
cargo binding and transport by ubiquitin recognition. Aar2p could be a link between 
double strand break repair and proteasome degradation as proposed for other proteins 
(Ben-Aroya et al., 2010). DNA damage can target Aar2p to sites of double strand 
breaks, probably through S331 phosphorylation. There, Aar2p can bind DSB 
proteins and mediate its transport to the proteasome. Sustaining this idea, a ts aar2 
mutant was observed to promote chromosome instability (Ben-Aroya et al., 2010). 
This mutant could have an effect on DNA damage repair and therefore cause the 
chromosome instability. 
In the prey list I find also telomeric regions of three chromosomes, together 
with chromatin-binding/remodeling proteins and one telomere-binding protein. 
DAmP alleles of splicing factors have been found to affect telomere length in 
budding yeast. Mutations in PRP4, PRP22, PRP31, PRP38, PRP43 and NTR2 
caused short telomeres (Ungar et al., 2009). Prp4p, Prp31p and Prp38p are 
components of the tri-snRNP (Stevens & Abelson, 1999); Prp22p and Prp43p are 
DEAH-box RNA-dependent ATPase/ATP-dependent RNA helicases. Prp22p is 
responsible for mRNA release from the spliceosome (Schneider et al., 2002). Prp38p 
together with Ntr2p mediates intron-lariat complex release and spliceosome 
disassembly (Martin et al., 2002; Tsai et al., 2005). 
On the other hand, DAmP alleles of AAR2 and SAD1 cause long telomeres 
(Ungar et al., 2009). Sad1p is a conserved protein required for U4 assembly into the 
U4/U6 dimer (Lygerou et al., 1999). 
Proteins required for the later steps of the splicing reaction or even 
spliceosome disassembly seem to be involved in telomere elongation. On the other 
hand, the proteins required for the earliest steps of spliceosome assembly (with 
indirect effects on tri-snRNP formation) appear to shorten the telomeres. These 
opposing effects on telomere length are rather interesting. It seems that the 
equilibrium between spliceosome assembly/disassembly contributes in some way to 
telomere size maintenance. 
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The chromosome ends are protected by the telomeres from being recognized as 
DNA breaks and from getting shorter as a consequence of DNA replication 
(Blackburn, 2005). Therefore, Aar2p association with telomeres, an autonomously 
replicating sequence, a telomere-binding protein and chromatin binding/remodeling 
proteins can be related to its putative involvement in DNA damage repair. Aar2p can 
be targeted to sites of active replication by a mechanism similar to that proposed for 
DNA damage repair. Once at the replication sites, it can mediate rearrangements in 
chromosome architecture on replication sites. Alternatively, Aar2p could be directed 
to the DNA by default and its mode of action would vary according to the scenario 
presented, either a double strand break or active replication. 
In conclusion, this study contributes to the current knowledge about Aar2p role 
on U5 snRNP biogenesis and unveils new study potential for this protein. 
 
7.3 Future work 
This thesis raises new questions to be answered regarding Aar2p function in 
both U5 snRNP biogenesis and DNA damage repair. In the following sections new 
directions are proposed for the study of Aar2p in these two processes. 
 
7.3.1 Aar2p role in U5 snRNP maturation 
One fundamental experiment to be done, and already suggested in Chapter 5, is 
to study the effect of the phosphomutants in two plasmid shuffle strains, one MATa 
and another MATα. This may clarify whether the different effects observed in 
Chapters 4 and 5 are mating type-specific or not. 
It would be interesting to combine the Aar2p phosphomutants with 
ΔNLS-Prp8p. If Aar2p really is an accessory transport factor for Prp8p, one or more 
of the phosphomutants might block Prp8p nuclear import completely and lead to 
lethality. At the same time the individual phosphomutants effect on Prp8p and Aar2p 
localisation can be assessed by fluorescence microscopy. Different combinations of 
phosphomutations can also be tested in this process. 
Additionally the role of ubiquitination in U5 snRNP biogenesis can be verified. 
This can be done by immunoprecipitation to test whether Aar2p really recognizes 
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and binds Prp8p-ubiquitin to mediate its nuclear import; and also testing if ubiquitin 
recognition disruption affects Prp8p localisation. 
Prp8p rp mutants accumulate Aar2p/Prp8p/U5 snRNP in the nucleus and have 
reduced levels of Brr2p/Prp8p/U5 snRNP leading to splicing defects (Boon et al., 
2007). This happens probably due to a stabilization of the Aar2p/Prp8p interaction, 
inhibiting Brr2p binding to Prp8p. Consequently, the Aar2p-S253E mutation may 
reverse this effect. A way to test this is to combine the Prp8p rp mutants with Aar2p-
S253A/E and study the effect on cell growth and pre-mRNA splicing. Aar2p S253A 
should exacerbate the rp phenotype and S253E should rescue it. At the same time the 
levels of Aarp2/Prp8p and Brr2p/Prp8p can be checked by glycerol gradient 
fractionation followed by Prp8p immunoprecipitation. Aar2p-S253A should cause an 
increase in Aarp2/Prp8p and a decrease in Brr2p/Prp8p levels. The reverse effect is 
expected with Aar2p-253E. 
A relevant and yet unidentified player in the updated U5 snRNP biogenesis 
model is kinase X (Figure 7.1). It is important to find the identity of this kinase, 
which seems to have a role in regulation of the Aar2p/Prp8p interaction. Although 
kinase/substrate interactions are usually very transient, this can be approached by 
Aar2p immunoprecipitation from yeast extracts followed by mass spectrometry. The 
kinases found amongst the interactors can be tested for Aar2p/Prp8p interaction 
regulation. 
 
7.3.2 Aar2p, chromosomes and DNA damage repair 
Investigating a role for Aar2p in DNA damage repair and chromosome biology 
should start by confirming the major interactions described in this study. The 
robustness of the prey interactions with Aar2p1-170 can be tested in the presence of 
increasing 3AT concentrations. At the same time Y2H assays can be set up where the 
prey clones can be used as bait, and Aar2p1-170 as prey to confirm the reciprocity of 
the interaction. 
The confirmed interactions can be tested in vivo by immunoprecipitation 
performed in cells subjected to DNA damage, primarily to UV-induced DNA 
damage. The relative importance of each Aar2p phosphosite in this process can be 
accessed studying the effect its effect under the same DNA damage conditions. 
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APPENDIX - Mass-spectrometry data 
 
A) Technique description 
F. de Lima Alves in J. Rappsilber lab identified the candidate phosphosites for 
Aar2p. That was done using an LTQ-Orbitrap mass spectrometer (ThermoElectron) 
coupled on line to an Agilent 1100 binary nanopump and an HTC PAL autosampler 
(CTC Analytics). To prepare an analytical column with a self-assembled particle frit 
(25), C18 material (ReproSil-Pur C18-AQ 3 µm, Dr. Maisch, GmbH) was packed 
into a spray emitter (75 µm inner diameter, 8 µm opening, 70 mm length; New 
Objectives) using an air pressure pump (Proxeon Biosystems). Mobile phase A 
consisted of water, 5% acetonitrile, and 0.5% acetic acid. Mobile phase B consisted 
of acetonitrile and 0.5% acetic acid. The gradient used for each sample was 2 h. 
Peptides were loaded onto the column at a flow rate of 0.7 µL/min and eluted at a 
flow rate of 0.3 µL/min. For a 2 h gradient run, elution used a gradient from 0% B to 
20% B over 75 min and then from 20% B to 80% B over 13 min. Fourier transform 
mass spectrometry spectra were recorded at 30,000 resolution, and the six most 
intense peaks of the MS scan were selected in the ion trap for fragmentation (normal 
scan; wideband activation; filling, 7.5 × 105 ions for MS scan and 1.5 × 104 ions for 
MS/MS; maximum fill time, 150 ms; dynamic exclusion for 60 s). Raw files were 
processed using DTA Super Charge (v.1.19), Mascot (v.2.2.0) and MS Quant 
(v.1.4.3a74) software. 
Searches were conducted using Mascot (version 2.2.0) against a SwissProt 
database containing Saccharomyces Cerevisiae sequence (6556 sequences). The 
following search parameters were used: mass tolerance for precursor ions, 6 ppm; 
mass tolerance for fragment ions, 0.6 Da; enzyme specificity, fully tryptic (no 
cleavage N-terminally of proline); allowed number of missed cleavages, 2; fixed 
modification, carbamidomethylation on cysteine; variable modification, oxidation on 








Below are included representative spectra for each of the identified 




This phosphopeptide was the least abundant of the 5 sites, being identified in 
one peptide with the thermolysin digest. Peptide represented in the spectrum with a 











This phosphosite was identified in one peptide with the elastase digest. Peptide 











This phosphosite was identified in 8 peptides with the elastase digest and in 







This phosphosite was very abundant and identified in all the digests performed. 
It was detected in 7 peptides with trypsin, 21 peptides with proteinase K, 26 peptides 
with elastase and 54 peptides with thermolysin. Peptide in this spectrum with a score 








This phosphosite was identified in one peptide with the trypsin digest and in 
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